( (TITLE (FRAG (NP (NP (NN Function) (, ,) (NN expression) (CC and) (NN localization)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP-LOC (IN in) (NP (NP (NNS platelets)) (CC and) (NP (JJ red) (NN blood) (NNS cells))))) (: :) (NP (NP (NNS Insights)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT an) (NML (NN annexin) (NN A7)) (JJ mutant) (NN mouse))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NN Annexin) (NN A7)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (NP (NN Ca2+) (HYPH -) (CC and) (NN phospholipid)) (HYPH -) (VBG binding)) (NN protein)) (VP (VBN expressed) (NP (-NONE- *)) (PP-MNR (IN as) (NP (NP (DT a) (NML (QP (CD 47) (CC and) (CD 51)) (NN kDa)) (NN isoform)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN involved) (NP-2 (-NONE- *)) (PP (IN in) (NP (NML (NN membrane) (NN fusion)) (NNS processes)))))))))))))))) (. .)) )
( (S (ADVP-TMP (RB Recently)) (NP-SBJ-1 (DT the) (NML (CD 47) (NN kDa)) (NN isoform)) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS erythrocytes)) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (PRP it)) (VP (VBD was) (VP (VBN proposed) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT a) (JJ key) (NN component)) (PP (IN in) (NP (NP (NP (DT the) (NN process)) (PP (IN of) (NP (DT the) (ADJP (NN Ca2+) (HYPH -) (JJ dependent)) (NN vesicle) (NN release)))) (, ,) (NP (NP (DT a) (NN process)) (SBAR (WHPP-4 (IN with) (WHNP (WDT which))) (S (NP-SBJ (JJ red) (NN blood) (NNS cells)) (VP (MD might) (VP (VB protect) (NP (PRP themselves)) (PP (IN against) (NP (NP (DT an) (NN attack)) (PP (IN by) (NP (PP (IN for) (NP (NN example))) (NN complement) (NNS components))))) (PP-4 (-NONE- *T*)))))))))) (ADVP-LOC-3 (-NONE- *T*)))))))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (NP-SBJ-1 (NP (DT The) (NN role)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells)))) (VP (VBD was) (VP (VBN addressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS erythrocytes)) (PP (IN from) (NP (NML (JJ anxA7) (SYM -) (HYPH /) (SYM -)) (NNS mice))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (DT the) (ADJP (NN Ca2+) (HYPH -) (VBN mediated)) (NN vesiculation) (NN process)) (VP (VBD was) (RB not) (VP (VBN impaired) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB Also)) (, ,) (NP-SBJ-1 (DT the) (NN membrane) (NN organization)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (RB not) (VP (TO to) (VP (VB be) (VP (VBN disturbed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN assessed) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN gradient) (NN fractionation)) (NNS studies)))))))))))) (. .)) )
( (S (ADVP (RB Instead)) (, ,) (NP-SBJ (NP (NN lack)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBD led) (PP (IN to) (NP (NP (NP (DT an) (JJ altered) (NN cell) (NN shape)) (CC and) (NP (VBN increased) (JJ osmotic) (NN resistance))) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells)))))) (. .)) )
( (S (NP-SBJ-1 (NN Annexin) (NN A7)) (VP (VBD was) (ADVP (RB also)) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNS platelets))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT these) (NNS cells))) (NP-SBJ (PRP$ its) (NN loss)) (VP (VBD led) (PP (IN to) (NP (NP (DT a) (ADJP (RB slightly) (JJR slower)) (NN aggregation) (NN velocity)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN compensated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT an) (VBN increased) (NN number)) (PP (IN of) (NP (NNS platelets))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS results)) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB rule) (PRT (RP out)) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (NP (NML (NN membrane) (NN fusion)) (NNS processes)) (VP (VBG occurring) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells))))))))))) (. .)) )
( (S (ADVP (RB Instead)) (NP-SBJ-1 (DT the) (NN protein)) (VP (MD might) (VP (VB be) (VP (VBN involved) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN organization)) (PP (IN of) (NP (DT the) (NN membrane) (NN cytoskeleton)))))))) (. .)) )
( (S (NP-SBJ (JJ Red) (NN blood) (NNS cells)) (VP (MD may) (VP (VB represent) (NP (NP (DT an) (JJ appropriate) (NN model)) (SBAR (WHADVP-1 (-NONE- *0*)) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (JJ cellular) (NNS processes)))) (ADVP-1 (-NONE- *T*))))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (CC both) (NML (NN annexin) (NN A7)) (NNS isoforms))) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells)))) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (JJ small) (NN isoform))) (PP-LOC (IN in) (NP (NNS platelets))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT both) (NN cell) (NNS types))) (NP-SBJ (NP (DT the) (NN loss)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBZ impairs) (NP (JJ cellular) (NNS functions))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS defects)) (VP (VBN observed) (NP (-NONE- *)))) (VP (VBP are) (ADVP (RB however)) (RB not) (ADJP-PRD (JJ compatible) (PP (IN with) (NP (NP (DT a) (JJ crucial) (NN role)) (PP (IN for) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (NML (NN membrane) (NN fusion)) (NNS processes))) (PP-LOC (IN in) (NP (DT these) (NN cell) (NNS types))))))) (. .)) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NN Annexin) (NN A7)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (NP (NN Ca2+) (HYPH -) (CC and) (NN phospholipid)) (HYPH -) (VBG binding)) (NN protein)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT the) (NN agent)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD mediated) (NP (NP (NP (NP (NN aggregation)) (PP (IN of) (NP (NN chromaffin) (NNS granules)))) (CC and) (NP (NP (NN fusion)) (PP (IN of) (NP (NN phospholipid) (NNS membranes))))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Ca2+))))))))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN activity)) (VP (VBD led) (PP (IN to) (NP (NP (DT the) (NN proposal)) (PP (IN of) (NP (NP (NP (NN annexin) (NN A7) (POS 's)) (NN involvement)) (PP (IN in) (NP (NP (DT the) (JJ exocytotic) (NN secretion)) (PP (IN of) (NP (NNS catecholamines))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (DT The) (NN protein)) (VP (VBZ belongs) (PP (IN to) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (ADJP (RB evolutionarily) (VBN conserved)) (NN proteins)) (PP (IN of) (NP (DT a) (JJ bipartite) (NN structure))) (PP (IN with) (NP (NP (NP (DT a) (JJ variable) (ADJP (NN N) (HYPH -) (JJ terminal)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (DT a) (VBN conserved) (ADJP (NN C) (HYPH -) (JJ terminal)) (NML-1 (-NONE- *RNR*)))) (NML-1 (NN domain))))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (ADJP (NN C) (HYPH -) (JJ terminal)) (NN domain)) (VP (VBZ is) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (DT the) (NML (NN Ca2+) (HYPH -) (CC and) (NN phospholipid)) (HYPH -) (VBG binding)))))) (, ,) (S (NP-SBJ-1 (DT the) (ADJP (NN N) (HYPH -) (JJ terminal)) (NN domain)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB confer) (NP (JJ functional) (NN diversity))))) (PRN (-LRB- [) (NP (NP (CD 2)) (PP (SYM -) (NP (CD 4)))) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN binding)) (PP (IN to) (NP (ADJP (RB negatively) (JJ charged)) (NNS phospholipids)))) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN mediated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN Ca2+) (NNS ions))))))))) (. .)) )
( (S (NP-SBJ (NN Annexin) (NN A7)) (VP (VBZ is) (ADJP-PRD (JJ unique)) (SBAR-PRP (IN in) (IN that) (S (NP-SBJ (PRP it)) (VP (VBZ carries) (NP (NP (DT an) (ADJP (RB extraordinarily) (ADJP (JJ long) (CC and) (JJ hydrophobic))) (NN amino) (NN terminus)) (PP (IN with) (NP (QP (JJR more) (IN than) (CD 100)) (NN amino) (NNS acids)))))))) (. .)) )
( (S (NP-SBJ (JJ Alternative) (NN splicing)) (VP (VBZ gives) (NP (NN rise)) (PP (IN to) (NP (NP (CD two) (NNS isoforms)) (PP (IN of) (NP (QP (CD 47) (CC and) (CD 51)) (NN kDa)))))) (. .)) )
( (S (NP-SBJ (DT Both) (NNS isoforms)) (VP (VBP differ) (PP (IN by) (NP (NP (DT an) (JJ additional) (NN cassette) (NN exon)) (ADJP (JJ located) (PP-LOC (IN in) (NP (NP (DT the) (JJ first) (NN third)) (PP (IN of) (NP (DT the) (ADJP (NN N) (HYPH -) (JJ terminal)) (NN domain))))))))) (. .)) )
( (S (S (NP-SBJ (JJS Most) (NNS tissues)) (VP (VBP harbor) (NP (RB only) (DT the) (NML (CD 47) (NN kDa)) (NN isoform)))) (, ,) (S (NP-SBJ-1 (DT both) (NNS forms)) (VP (VBP are) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN brain) (CC and) (NN heart))) (, ,) (SBAR-ADV (WHADVP-2 (IN while)) (S (NP-SBJ-3 (DT the) (JJ large) (NN isoform)) (VP (VBZ is) (ADVP (RB exclusively)) (VP (VBN expressed) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (JJ mature) (JJ skeletal) (NN muscle))) (ADVP-2 (-NONE- *T*))))))))) (. .)) )
( (S (PP (IN At) (NP (DT the) (JJ cellular) (NN level))) (NP-SBJ-1 (NN annexin) (NN A7)) (VP (MD can) (VP (VB be) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (DT the) (NN cytosol))) (, ,) (PP (IN at) (NP (DT the) (NN plasma) (NN membrane))) (, ,) (PP (IN around) (NP (DT the) (NN nucleus))) (, ,) (PP (IN at) (NP (NP (JJ vesicular) (NNS structures)) (PP (VBG including) (NP (JJ adrenal) (NN chromaffin) (NNS granules))))) (, ,) (CC and) (PP (IN at) (NP (DT the) (NML (NN t) (HYPH -) (NN tubule)) (NN system)))) (PRN (-LRB- [) (NP (CD 5) (, ,) (CD 6)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NN Annexin) (NN A7)) (VP (VP (VBZ translocates) (PP (IN to) (NP (NNS membranes))) (PP-MNR (IN in) (NP (DT a) (ADJP (NN Ca2+) (HYPH -) (JJ dependent)) (NN fashion)))) (CC and) (VP (, ,) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (JJ intracellular) (NN Ca2+) (NNS levels)) (VP (VBP rise) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (ADVP-TMP (RB sequentially)) (VBZ redistributes) (PP (PP (IN to) (NP (NP (DT the) (NN plasma)) (CC and) (NP (DT the) (JJ nuclear) (NN membrane)))) (CONJP (RB as) (RB well) (IN as)) (PP (IN to) (NP (JJ intracellular) (NNS vesicles)))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ associates) (PP (IN with) (NP (NN lipid) (NNS rafts))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NN Lipid) (NNS rafts)) (VP (VBP play) (NP (DT a) (JJ key) (NN role)) (PP (PP (IN in) (NP (NN membrane) (NN budding))) (CC and) (PP (IN in) (NP (NP (NN vesiculation) (NNS processes)) (PP (JJ such) (IN as) (NP (AFX endo) (HYPH -) (CC and) (NN exocytosis)))))) (PRN (-LRB- [) (NP (NP (CD 8)) (PP (SYM -) (NP (CD 10)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (CD Two) (VBG binding) (NNS partners)) (PP (IN of) (NP (NN annexin) (NN A7)))) (NP-2 (-NONE- *ICH*))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)) (, ,) (NP-2 (NP (NN sorcin)) (CC and) (NP (NN galectin) (HYPH -) (CD 3))) (PRN (-LRB- [) (NP (NP (CD 11)) (PP (SYM -) (NP (CD 13)))) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NN Sorcin)) (VP (VP (VBZ is) (NP-PRD (DT a) (ADJP (NN Ca2+) (HYPH -) (VBG binding)) (NN protein))) (CC and) (VP (VBZ belongs) (PP (IN to) (NP (DT the) (NML (NN penta) (NML (NN EF) (HYPH -) (NN hand)) (NN protein)) (NN family)))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))) (. .)) )
( (S (PP (IN Like) (NP (NN annexin) (NN A7))) (NP-SBJ (PRP it)) (VP (VBZ binds) (PP (IN to) (NP (NNS membranes))) (PP-MNR (IN in) (NP (DT a) (ADJP (NN Ca2+) (HYPH -) (JJ dependent)) (NN manner)))) (. .)) )
( (S (NP-SBJ-1 (NN Sorcin)) (ADVP (RB also)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NN interaction) (NN partner)) (PP (IN of) (NP (DT the) (NN ryanodine) (NN receptor)))))))) (, ,) (CC and) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB modulate) (NP (PRP$ its) (NN function)))))) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN influence)) (PP (IN of) (NP (DT the) (NML (NML (NN sorcin) (HYPH /) (NN annexin)) (NN A7)) (NN interaction))) (PP (IN on) (NP (DT the) (NN ryanodine) (NN receptor)))) (VP (VBZ is) (ADJP-PRD (JJ unknown))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Sorcin)) (CC and) (NP (NN annexin) (NN A7))) (VP (VBP are) (VP (VBN coexpressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT all) (NNS tissues)) (VP (VBN examined) (NP (-NONE- *)) (ADVP-TMP (RB so) (RB far))))) (PRN (-LRB- [) (NP (CD 11)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN binding)) (PP (IN of) (NP (NP (NN annexin) (NN A7)) (CC and) (NP (NN sorcin))))) (VP (VP (VBZ is) (ADJP-PRD (NN Ca2+) (HYPH -) (JJ dependent))) (CC and) (VP (VBZ occurs) (PP (IN at) (NP (NML (JJ micromolar) (NN Ca2+)) (NNS concentrations))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBG binding) (NNS sites)) (VP (VBP have) (VP (VBN been) (VP (VBN localised) (NP-1 (-NONE- *)) (PP (PP (IN to) (NP (NP (DT the) (ADJP (NN amino) (JJ terminal)) (NML (NN GGYY) (CC and) (NN GYGG)) (NNS motifs)) (PP-LOC (IN in) (NP (NN sorcin))))) (CC and) (PP (IN to) (NP (NP (DT the) (NN GYPP) (NN motif)) (PP-LOC (IN in) (NP (NP (DT the) (NN amino) (NN terminus)) (PP (IN of) (NP (NN annexin) (NN A7))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN proteins)) (VP (VBP bind) (PP (IN to) (NP (DT each) (JJ other))) (PP (IN with) (NP (NP (DT a) (NN stoichiometry)) (PP (IN of) (NP (NP (CD two) (NN sorcin) (NNS molecules)) (PP (IN per) (NP (NML (NN annexin) (NN A7)) (NN molecule))))))) (PRN (-LRB- [) (NP (CD 12)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NN Galectin) (HYPH -) (CD 3)) (VP (VBZ is) (NP-PRD (NP (NP (DT a) (JJ multifunctional) (JJ oncogenic) (NN protein)) (PP (IN with) (NP (DT an) (JJ anti-apoptotic) (NN activity)))) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (PP (IN in) (NP (NP (DT the) (JJ extracellular) (NN space)) (, ,) (PP-LOC (IN in) (NP (DT the) (NML (NN nucleus) (CC and) (NN cytoplasm)))))) (CC and) (PP (IN in) (NP (NNS mitochondria))))))) (. .)) )
( (S (NP-SBJ (JJ Cytoplasmic) (NN galectin) (HYPH -) (CD 3)) (VP (VP (VBZ correlates) (PP (IN with) (NP (NN tumor) (NN progression)))) (CC and) (VP (VBZ protects) (NP (JJ mitochondrial) (NN integrity)))) (. .)) )
( (S (NP-SBJ (NP (NN Down) (NN regulation)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VP (VBZ prevents) (NP (NP (NML (NN galectin) (HYPH -) (NN 3)) (NN translocation)) (PP (IN to) (NP (DT the) (JJ perinuclear) (NN membrane))))) (CC and) (VP (VBZ increases) (NP (NML (NN galectin) (HYPH -) (NN 3)) (NN secretion)))) (. .)) )
( (S (PP (IN For) (NP (NN annexin) (NN A7))) (NP-SBJ-1 (NP (DT a) (NN role)) (PP (IN for) (NP (NP (NML (NN galectin) (HYPH -) (NN 3)) (NN trafficking)) (, ,) (NP (NN apoptosis) (NN regulation)) (, ,) (CC and) (NP (JJ mitochondrial) (NN integrity))))) (VP (VBD was) (VP (VBN proposed) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ cellular) (NN role)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBZ is) (RB not) (ADVP (RB well)) (VP (VBN understood) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (PRP It)) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (VP (TO to) (VP (VB regulate) (CC and) (VB stabilize) (NP (NN membrane) (NNS domains)))) (CC and) (VP (TO to) (VP (VB have) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN Ca2+) (NN homeostasis)) (CC and) (NP (ADJP (NN Ca2+) (HYPH -) (JJ dependent)) (NN signaling) (NNS pathways)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS proposals)) (VP (VBP are) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS data)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (NP (NN analysis)) (PP (IN of) (NP (ADJP (NP (NN annexin) (NN A7)) (JJ deficient)) (NN mouse) (NNS mutants)))))))))) (. .)) )
( (S (NP-SBJ-1 (CD Two) (NML (NN annexin) (NN A7)) (NN 129Sv) (JJ null) (NNS mice) (NNS strains)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (ADVP (RB independently)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (JJ different) (NN strategy)))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (CD one)) (PP (IN of) (NP (NP (NNP Srivastava)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 16)) (-RRB- ]))))) (VP (VBZ is) (ADJP-PRD (JJ lethal))) (. .)) )
( (S (NP-SBJ (JJ Heterozygous) (NNS mice)) (VP (VBP exhibit) (NP (NP (DT an) (NML (NN insulin) (NN secretion)) (NN defect)) (CC and) (NP (NN tumor) (NNS phenotypes)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ null) (NN strain)) (VP (VBN reported) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP Herr)) (ADVP-ETC (FW et) (FW al.)))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])))) (VP (VP (VBZ is) (ADJP-PRD (JJ viable) (, ,) (JJ healthy))) (, ,) (CC and) (VP (VBZ shows) (NP (DT no) (NML (NML (NML (NN insulin) (NN secretion)) (NN defect)) (CC or) (NML (JJ other) (JJ obvious) (NNS defects)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-LOC (IN in) (NP (VBN isolated) (NNS cardiomyocytes))) (NP-SBJ-1 (DT the) (ADJP (NN frequency) (HYPH -) (VBN induced)) (NN shortening)) (VP (VBZ is) (VP (VBN disturbed) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (NP (JJ red) (NN blood) (NNS cells)) (CC and) (NP (NNS platelets))) (PP (IN of) (NP (DT the) (NML (JJ anxA7) (SYM -) (HYPH /) (SYM -)) (NN mutant))))))))) (. .)) )
( (S (ADVP (RB Generally)) (, ,) (S (S (NP-SBJ-1 (NP (JJ red) (NN blood) (NNS cells)) (CC and) (NP (NNS platelets))) (VP (VBD were) (VP (VBN thought) (RB not) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB contain) (NP (NN annexin) (NN A7)))))))) (CC and) (S (ADVP-TMP (RB only) (RB recently)) (NP-SBJ-2 (DT the) (NML (CD 47) (NN kDa)) (NN isoform)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (NP-2 (-NONE- *)) (PP (IN as) (NP (NP (NN component)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (JJ Red) (NN blood) (NNS cells)) (VP (VBP undergo) (NP (NP (JJ various) (ADJP (JJ biochemical) (CC or) (JJ morphological)) (NNS changes)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (ADJP (NN Ca2+) (HYPH -) (JJ dependent)) (NNS processes))))))))) (PRN (-LRB- [) (NP (CD 18) (, ,) (CD 19)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (CD One)) (PP (IN of) (NP (PRP them)))) (VP (VBZ is) (NP-PRD (NP (NP (DT the) (NN release)) (PP (IN of) (NP (ADJP (NN hemoglobin) (HYPH -) (VBG containing)) (NNS exovesicles)))) (VP (VBG occurring) (ADVP-LOC (ADVP (FW in) (FW vivo)) (CONJP (RB as) (RB well) (IN as)) (ADVP (FW in) (FW vitro))))) (PRN (-LRB- [) (NP (CD 7) (, ,) (CD 20)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN process)) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB represent) (NP (NP (DT a) (JJ protective) (NN method)) (PP (IN of) (NP (DT the) (JJ red) (NN blood) (NN cell))) (PP (IN against) (NP (NP (DT an) (NN attack)) (PP (IN by) (NP (PP (IN for) (NP (NN example))) (NN complement) (NNS components))))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Red) (NN blood) (NNS cells)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP lack) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB vesiculate))))))))) (VP (VB cause) (NP (DT a) (NN disease)) (PP (IN with) (NP (NP (NML (JJ red) (NN blood) (NN cell)) (NN destruction)) (CC and) (NP (NN haemoglobinuria)))) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBP exist) (NP (NP (NP (NP (CD two) (NNS types)) (PP (IN of) (NP (NNS vesicles)))) (, ,) (NP (AFX micro) (HYPH -) (CC and) (NNS nanovesicles))) (PP (IN with) (NP (NP (DT a) (NN size)) (PP (IN of) (NP (NP (CD 180) (NN nm)) (CC and) (NP (CD 60) (NN nm))))))) (, ,) (ADVP (RB respectively))) (. .)) )
( (S (S (NP-SBJ-2 (PRP They)) (VP (VBP are) (VP (VBN enriched) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (ADJP (NP (NN cholesterol) (CC and) (NN sphingolipid)) (JJ rich)) (NML (NN lipid) (NN raft)) (NNS domains)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN proteins)) (PP (IN like) (NP (NP (NN acetylcholinesterase)) (, ,) (NP (NP (NN cell) (NN surface) (NN proteins)) (PP (VBG including) (NP (DT a) (NN complement) (NN receptor)))) (, ,) (CC and) (NP (NP (DT the) (NML (NN lipid) (NN raft)) (NN proteins)) (NP (NN stomatin) (CC and) (NN flotillin)))))))))))))))) (, ,) (CC but) (S (NP-SBJ (PRP they)) (VP (VBP lack) (NP (DT any) (JJ cytoskeletal) (NN protein)) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (PRP they)) (VP (VBP contain) (NP (NP (NP (NN sorcin)) (CC and) (NP (NN annexin) (NN A7))) (VP (VBN attached) (NP (-NONE- *)) (PP (IN to) (NP (DT the) (NN lipid) (NNS rafts)))))) (. .)) )
( (S (NP-SBJ (DT Both) (NN proteins)) (VP (VBP are) (ADJP-PRD (RBR more) (JJ abundant)) (PP-LOC (IN in) (NP (NNS nanovesicles)))) (. .)) )
( (S (NP-SBJ (DT The) (NN vesicle) (NN formation)) (VP (VBZ goes) (PRT (RP along)) (PP (IN with) (NP (NP (JJ several) (JJ other) (NNS changes)) (PP-LOC (IN in) (NP (DT the) (JJ red) (NN blood) (NN cell))) (PP (IN like) (NP (NP (JJ cytoskeletal) (NNS rearrangements)) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (NN phospholipid) (NN orientation))) (PP-LOC (IN in) (NP (DT the) (JJ cellular) (NN membrane))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NML (NN Annexin) (NN A7)) (NN expression)) (PP-LOC (PP (IN in) (NP (NP (JJ red) (NN blood) (NNS cells)) (, ,) (NP (ADJP (NP (JJ red) (NN blood) (NN cell)) (VBN derived)) (NNS exovesicles)))) (CC and) (PP (IN in) (NP (NNS platelets)))))) )
( (S (NP-SBJ (NP (NNP Salzer)) (ADVP-ETC (FW et) (FW al.))) (ADVP-TMP (RB recently)) (VP (VBD reported) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT the) (NML (CD 47) (NN kDa)) (NN isoform)) (PP (IN of) (NP (NP (NN annexin) (NN A7)) (CC and) (NP (NP (PRP$ its) (NN partner)) (NP (NN sorcin))))) (PP-LOC (IN in) (NP (NP (NN micro) (HYPH -) (CC and) (NNS nanovesicles)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (JJ red) (NN blood) (NNS cells)) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (PRP they)) (VP (VP (VP (VBP are) (VP (VBN located) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN lumen))))) (CC and) (VP (VBP are) (ADVP (RB also)) (VP (VBN enriched) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN membrane) (NNS rafts)))))) (ADVP-LOC-3 (-NONE- *T*))))))))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP have) (ADVP-TMP (RB now)) (VP (VBN extended) (NP (DT these) (NNS findings)))) (CC and) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (CD 51) (NN kDa)) (NN isoform)) (VP (VBZ is) (ADJP-PRD (JJ present)) (ADVP (RB as) (RB well))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (JJ western) (NNS blots)) (PP (IN of) (NP (JJ human) (JJ red) (NN blood) (NNS cells))))) (NP-SBJ-1 (DT the) (NML (QP (CD 47) (CC and) (CD 51)) (NN kDa)) (NNS isoforms)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN mAb) (CD 203–217)))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-2=1 (DT The) (NML (CD 47) (NN kDa)) (NN isoform)) (VP (VBD was) (VP=5 (VBN detected) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN silver) (VBN stained)) (NNS gels)))))) (CC and) (S (NP-SBJ-4=1 (NP (PRP$ its) (NN identity)) (PP (IN with) (NP (NN annexin) (NN A7)))) (VP=5 (VBN confirmed) (NP-4 (-NONE- *)) (PP-MNR (IN by) (NP (NN peptide) (NN mass) (NN fingerprinting))) (PRN (-LRB- -LRB-) (S (NP-SBJ-3 (NNS data)) (RB not) (VP (VBN shown) (NP-3 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (CD 51) (NN kDa)) (NN isoform)) (VP (VBD was) (ADVP (RB only)) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ western) (NNS blots))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NP (NN Expression)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP-LOC (IN in) (NP (NP (JJ human) (JJ red) (NN blood) (NNS cells) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (CC and) (NP (JJ human) (NNS platelets) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Protein) (NNS homogenates)) (VP (VBD were) (VP (VBN separated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN SDS) (HYPH -) (NN PAGE))) (PRN (-LRB- -LRB-) (NP (NML (CD 12) (NN %)) (NN acrylamide)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT The) (VBG resulting) (JJ western) (NN blot)) (VP (VBD was) (VP (VBN probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN mAb) (CD 203–217)))))) (, ,) (S (NP-SBJ (NN visualization)) (VP (VBD was) (PP-PRD (IN by) (NP (NP (DT a) (JJ secondary) (ADJP (NN peroxidase) (VBN coupled)) (NN antibody)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN ECL)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT Both) (NNS isoforms)) (VP (VBP are) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells)))))) (, ,) (S (PP-LOC (IN in) (NP (NNS platelets))) (NP-SBJ (RB only) (DT the) (JJ small) (NN isoform)) (VP (VBZ is) (ADJP-PRD (JJ present)))) (. .))) )
( (S (NP-SBJ (NP (PRP$ Its) (NN presence)) (PP-LOC (IN in) (NP (NNS vesicles)))) (VP (VBD led) (PP (IN to) (NP (DT the) (NN suggestion) (, ,) (SBAR (IN that) (, ,) (S (PP (IN along) (PP (IN with) (NP (NN raft) (NNS domains)))) (, ,) (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ plays) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN membrane) (NN organization)) (CC and) (NP (DT the) (NN vesiculation) (NN process)))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB examine) (NP (DT this))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD analysed) (NP (NP (DT the) (NN ability) (S-2 (-NONE- *ICH*))) (PP (IN of) (NP (NP (JJ red) (NN blood) (NNS cells)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NN annexin) (NN A7)) (NML (NN knock) (NN out)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN anxA7) (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-))))))) (S-2 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB form) (NP (NNS exovesicles))))))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (NP (JJR better) (NN accessibility)) (CC and) (NP (JJR larger) (JJ available) (NNS amounts))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD led) (PP (IN to) (NP (JJ clear) (NNS results)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD included) (NP (NP (PRP$ our) (NNS data)) (VP (VBN obtained) (NP (-NONE- *)) (PP-MNR (IN with) (NP (JJ human) (NN blood)))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Independent) (PP (IN of) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN annexin) (NN A7))))))) (NP-SBJ-1 (NP (NP (DT both) (NNS types)) (PP (IN of) (NP (NNS exovesicles)))) (, ,) (NP (AFX micro) (HYPH -) (CC and) (NNS nanovesicles))) (, ,) (VP (VBD were) (VP (VBN released) (NP-1 (-NONE- *)) (PP-TMP (IN after) (NP (NML (NN Ca2+) (HYPH /) (NN ionophore)) (NN treatment))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN determined) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NN acetylcholine) (NN esterase)) (NN activity)) (CC and) (NP (JJ microscopic) (NN examination))))))))) (. .)) )
( (S (NP-SBJ (NN Annexin) (NN A7)) (VP (VBZ is) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NP (CC both) (NN vesicle) (NNS types)) (SBAR-LOC (WHADVP-1 (WRB where)) (S (NP-SBJ (PRP it)) (VP (VBZ is) (ADJP-PRD (RBR more) (JJ enriched)) (PP-LOC (IN in) (NP (NNS nanovesicles))) (ADVP-LOC-1 (-NONE- *T*))))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 2)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (NML (CD 51) (NN kDa)) (NN isoform)) (VP (VBZ is) (ADVP (RB only)) (ADJP-PRD (JJ detectable)) (PP-LOC (IN in) (NP (NNS nanovesicles)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN quantity)) (PP (IN of) (NP (DT both) (NN vesicle) (NNS types)))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN between) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN knock) (NN out))) (NML (JJ red) (NN blood) (NN cell)) (NNS vesicles))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN AChE) (HYPH -) (NNS values) (PRN (-LRB- -LRB-) (FRAG (NP (NN A405) (NNS nanovesicles)) (: :) (NP (QP (SYM ~) (CD 0.18)))) (: ;) (FRAG (NP (NN A405) (NNS microvesicles)) (: :) (NP (QP (SYM ~) (CD 0.9)))) (: ;) (NP (NP (DT both)) (, ,) (PP (IN for) (NP (NN wt) (CC and) (NN ko)))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (NP-SBJ (NN annexin) (NN A7)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB fuse) (NP (NNS membranes)))))))))) (, ,) (VP (VBZ is) (RB not) (NP-PRD (NP (DT a) (JJ key) (NN component)) (PP (IN in) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NML (JJ red) (NN blood) (NN cell)) (NNS exovesicles)))))))))))) (. .)) )
( (S (SBAR-TMP (WHADVP-2 (WRB When)) (S (NP-SBJ (PRP we)) (VP (VBD probed) (PP-PRP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN sorcin))))) (PP-LOC (IN in) (NP (UCP (NML (JJ wild) (NN type)) (CC and) (ADJP (JJ mutant))) (NNS vesicles))) (ADVP-TMP-2 (-NONE- *T*))))) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NN sorcin) (NNS levels)) (VP (VBD were) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ mutant) (NNS nanovesicles))))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 2)) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (CAPTION (NP (NP (NN Enrichment)) (PP (IN of) (NP (NP (NN annexin) (NN A7)) (CC and) (NP (NN sorcin)))) (PP-LOC (IN in) (NP (NP (NNS exovesicles)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (JJ red) (NN blood) (NNS cells)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Vesicles)) (PP (IN from) (NP (NP (NP (JJ wild) (NN type)) (-LRB- -LRB-) (NP (NN wt))) (-RRB- -RRB-) (CC and) (NP (NP (NML (JJ anxA7) (SYM -) (HYPH /) (SYM -)) (NN mutant)) (-LRB- -LRB-) (NP (NN ko)))))) (-RRB- -RRB-) (VP (VBD were) (VP (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NN Ca2+) (HYPH /) (NN ionophore)) (NN treatment)))) (, ,) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ differential) (NN centrifugation)))) (CC and) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (VBG immunoblotting))) (PP-MNR (IN with) (NP (NP (NN mAb) (NML (NML (CD 203)) (PP (SYM –) (NP (CD 217))))) (CC and) (NP (DT a) (NN sorcin) (JJ polyclonal) (NN antibody))))))) (. .))) )
( (CAPTION (S (PP (IN In) (ADJP (JJ general))) (, ,) (NP-SBJ (NP (NN annexin) (NN A7)) (CC and) (NP (NN sorcin))) (VP (VBP are) (ADJP-PRD (RBR more) (JJ abundant)) (PP-LOC (IN in) (NP (NNS nanovesicles)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NML (CD 51) (NN kDa)) (NN isoform)) (PP (IN of) (NP (NN annexin) (NN A7))) (PRN (-LRB- -LRB-) (NP (NNS arrows)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB only)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNS nanovesicles))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Samples)) (PP (IN of) (NP (DT both) (NNS vesicles) (NNS types)))) (VP (VBD were) (VP (VBN normalized) (NP-1 (-NONE- *)) (PP (VBG according) (PP (IN to) (NP (PRP$ their) (NML (NN acetylcholine) (NN esterase)) (NN activity)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Human) (JJ red) (NN blood) (NNS cells) (PRN (-LRB- -LRB-) (NP (NN co) (-RRB- -RRB-)))) (VP (VBD were) (VP (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN control)))) (CC and) (VP (VBD normalized) (NP-1 (-NONE- *)) (ADVP-MNR (RB independently))))) (. .))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB study) (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NN annexin) (NN A7)))) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells)))))) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (ADJP (NN self) (VBG forming)) (NN iodixanol) (NN density) (NNS gradients))) (. .)) )
( (S (NP-SBJ (DT Both) (NNS isoforms)) (VP (VBD were) (ADJP-PRD (JJ present)) (PP-LOC (PP (IN in) (NP (DT the) (JJ soluble) (NN fraction))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT the) (NN gradient) (NNS fractions)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-1 (PRP they)) (VP (VBP are) (VP (VBN assumed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NNS membranes))))))) (ADVP-LOC-2 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS membranes)) (VP (VBP are) (ADVP (RB exclusively)) (NP-PRD (NN plasma) (NNS membranes)) (SBAR-ADV (IN as) (S (NP-SBJ (JJ red) (NN blood) (NNS cells)) (VP (VBP are) (ADJP-PRD (JJ free) (PP (IN of) (NP (DT any) (NNS organelles)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN distribution)) (VP (VBD was) (ADVP (RB however)) (RB not) (ADJP-PRD (JJ homogeneous)) (PP-LOC (IN throughout) (NP (DT the) (NN gradient)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD could) (VP (VB reflect) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN to) (NP (NP (NN membrane) (NNS subdomains)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP have) (NP (JJ different) (NML (NML (NN lipid)) (CC or) (NML (NN lipid) (HYPH /) (NN protein))) (NN composition)))))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN discussed) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP Salzer)) (ADVP-ETC (FW et) (FW al.))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Likewise)) (, ,) (NP-SBJ (NN sorcin)) (VP (VBZ does) (RB not) (VP (VB exhibit) (NP (DT a) (JJ homogeneous) (NN distribution)) (PP-LOC (IN in) (NP (DT the) (NN gradient))))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (PRP it)) (VP (VBZ segregates) (PP (IN into) (NP (NP (NNS vesicles)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (RB not) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN annexin) (NN A7))))))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 3)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VP (VBD tested) (NP (NNS platelets)) (PP-PRP (IN for) (NP (NML (NN annexin) (NN A7)) (NN expression)))) (CC and) (VP (VBD detected) (NP (DT the) (NML (CD 47) (NN kDa)) (NN isoform)) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (CAPTION (NP (NP (NN Association)) (PP (IN of) (NP (NP (NN annexin) (NN A7)) (CC and) (NP (NN sorcin)))) (PP (IN with) (NP (JJ distinct) (NML (JJ red) (NN blood) (NN cell)) (NML (NN plasma) (NN membrane)) (NNS fractions))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (VBN Lysed) (JJ human) (JJ red) (NN blood) (NNS cells)) (VP (VBD were) (VP (VBN added) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (ADJP (NN self) (VBG forming)) (NN iodixanol) (NN density) (NN gradient))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN density)) (PP (IN of) (NP (DT the) (NN gradient)))) (VP (VBZ increases) (PP (PP (IN from) (NP (JJ left) (PRN (-LRB- -LRB-) (NP (NP (CD 1.06) (NNS g)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))) (PP (IN to) (NP (JJ right) (PRN (-LRB- -LRB-) (NP (NP (CD 1.20) (NNS g)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Fractions)) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN immunoblotting))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN mAb) (NML (NML (CD 203)) (PP (SYM –) (NP (CD 217))))) (CC and) (NP (DT the) (NN sorcin) (JJ polyclonal) (NN antibody))))))) (. .))) )
( (HEADING (S (NP-SBJ (NP (DT The) (NN lack)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBZ changes) (NP (NML (JJ red) (NN blood) (NN cell)) (NML (NML (NN morphology)) (CC and) (NML (JJ osmotic) (NN resistance))))))) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN component)) (PP (IN of) (NP (NML (JJ red) (NN blood) (NN cell)) (NNS vesicles))))))) (NP-SBJ (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (DT the) (NN protein)))))) (PP-LOC (IN in) (NP (DT the) (NML (NN anxA7) (SYM -) (HYPH /) (SYM -)) (NN mouse))) (PP-PRP (IN for) (NP (NML (JJ red) (NN blood) (NN cell)) (NML (NML (NN morphology)) (CC and) (NML (JJ osmotic) (NN resistance)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT a) (JJ standard) (`` ') (NN blood) (NN smear))) ('' ') (S (S (NP-SBJ (PRP we)) (VP (VBD did) (RB not) (VP (VB note) (NP (NP (DT a) (NN deformation)) (PP (IN of) (NP (DT the) (NNS cells))))))) (, ,) (S (ADVP (RB however)) (NP-SBJ (NML (JJ dark) (NN field)) (NN microscopy)) (VP (VBD revealed) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN shape) (CC and) (NN diameter)) (PP (IN of) (NP (DT the) (NML (JJ anxA7) (SYM -) (HYPH /) (SYM -)) (JJ red) (NN blood) (NNS cells))))))))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VBD had) (NP (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (JJR larger) (NN cell) (NN diameter)) (PP (IN of) (NP (CD 6.0) (NN μm))) (PP (VBN compared) (PP (IN to) (NP (NP (JJ wild) (NN type)) (PP (IN with) (NP (CD 5.7) (NNS μm)))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.015)))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 40)))) (-RRB- -RRB-))) (, ,) (NP (DT a) (ADJP (RB remarkably) (JJR lower)) (VBN emphasized) (JJ central) (NN impression)) (CC and) (NP (DT a) (ADJP (RBR more) (JJ flat)) (NN shape)) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 4)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT No) (JJ significant) (NN change)) (PP (IN in) (NP (DT the) (NML (NML (JJ mean) (JJ corpuscular) (NN volume)) (-LRB- -LRB-) (NML (NN MCV)))))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (NML (NN ADVIA) (CD 120)) (NN cell) (NN counter))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (CAPTION (NP (NP (NML (JJ Dark) (NN field)) (NN microscopy)) (PP (IN of) (NP (NP (JJ red) (NN blood) (NNS cells)) (PP (IN from) (NP (NML (NML (NML (JJ anxA7) (SYM -) (HYPH /) (SYM -)) (NN mutant) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC and) (NML (JJ wild) (NN type))) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ mean) (JJ cellular) (NNS diameters)) (VP (VBP are) (NP-PRD (NP (CD 6.0) (NNS μm)) (CC and) (NP (CD 5.7) (NNS μm))) (, ,) (ADVP (RB respectively))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NN size) (NNS differences)) (VP (VBP are) (ADJP-PRD (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.015)))) (: ;) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 40)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (FRAG (NP (NN Bar)) (, ,) (NP (CD 3) (NNS μm)) (. .))) )
( (S (NP-SBJ (NP (NN Shape) (CC and) (NN MCV)) (PP (IN of) (NP (DT a) (JJ red) (NN blood) (NN cell)))) (ADVP (RB essentially)) (VP (VB influence) (NP (PRP$ its) (NML (NML (NN function)) (CC and) (NML (JJ capillary) (NN passage))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ typical) (NN biconcave) (NN form)) (VP (VBZ depends) (PP (IN on) (NP (NP (JJ various) (NNS influences)) (PP (VBG including) (NP (NP (DT the) (NML (NN membrane) (NN lipid)) (NN composition)) (CC and) (NP (NP (DT the) (JJ submembranous) (NN cytoskeleton)) (PRN (-LRB- [) (CD 32) (-RRB- ])) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NN annexin) (NN A7)) (VP (MD might) (VP (VB play) (NP (DT a) (NN role)) (ADVP-LOC-1 (-NONE- *T*)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ osmotic) (NN resistance)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN resistance)) (PP (IN towards) (NP (NNS changes)))) (PP (IN in) (NP (DT the) (JJ extracellular) (JJ ionic) (NN strength))))))) (, ,) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ convenient) (NN assay)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN integrity))))))) (. .)) )
( (S (NP-SBJ-1 (PRP It)) (VP (VBZ is) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NP (NP (DT the) (NML (NN sodium) (NN chloride)) (NN concentration)) (SBAR (WHPP-2 (IN at) (WHNP (WDT which))) (S (NP-SBJ (JJ cellular) (NN lysis)) (VP (VBZ starts) (PP-2 (-NONE- *T*)))))) (-LRB- -LRB-) (NP (JJ minimal) (NN resistance))) (-RRB- -RRB-) (PP (IN up) (PP (IN to) (NP (NP (NP (DT a) (JJ complete) (NN lysis)) (-LRB- -LRB-) (NP (JJ maximal) (NN resistance))) (-RRB- -RRB-) (PP (IN of) (NP (DT the) (NNS cells)))))))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (JJ Osmotic) (NN resistance)) (VP (VBZ increases) (PP (IN with) (NP (NP (NP (JJR higher) (NN MCV)) (, ,) (NP (JJR larger) (NN surface) (NN area)) (CC and) (NP (NP (DT a) (JJR higher) (NN degree)) (PP (IN of) (NP (JJ cellular) (NN metabolism))))) (VP (VBG stabilizing) (NP (DT the) (JJ intracellular) (NN ion) (NNS levels)))))) (. .)) )
( (S (NP-SBJ (VBN Aged) (JJ red) (NN blood) (NNS cells)) (VP (VBP show) (NP (NP (DT a) (JJ lowered) (NN MCV)) (CC and) (NP (JJR lower) (JJ osmotic) (NN resistance))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (NNS properties)) (VP (MD can) (VP (VB be) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (JJ red) (NN blood) (NNS cells)) (PP (IN with) (NP (VBN lowered) (NN membrane) (NN permeability)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ osmotic) (NN resistance)) (PP (IN of) (NP (ADJP (NP (NN annexin) (NN A7)) (JJ deficient)) (JJ red) (NN blood) (NNS cells)))) (VP (VBZ is) (ADJP-PRD (RB significantly) (VBN increased)) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (NN type)) (NNS cells))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NML (JJ minimal) (NN resistance)) (NN value)) (PP (IN of) (NP (NML (NN knock) (NN out)) (NNS cells)))) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT a) (NML (CD 0.60) (NN %)) (NN NaCl) (NN solution)) (CC versus) (NP (NP (CD 0.65) (NN %)) (PP (IN for) (NP (NML (JJ wild) (NN type)) (NNS cells)))))))) (. .)) )
( (S (NP-SBJ-1 (NML (CD 50) (NN %)) (NN haemolysis)) (VP (VBZ is) (VP (VBN achieved) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (NP (NML (CD 0.516) (NN %)) (NN NaCl) (NN solution)) (PP (IN for) (NP (NN knock) (NN out)))) (CC versus) (NP (NP (NML (CD 0.564) (NN %)) (NN NaCl)) (PP (IN for) (NP (NML (JJ wild) (NN type)) (NNS cells)))))) (PRN (-LRB- -LRB-) (NP (NN mean) (NNS values)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.00066)))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8)))) (: ;) (NP (NN Fig.) (CD 5)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN resistance) (NN width)) (PP (IN of) (NP (DT the) (NML (NN knock) (NN out)) (NNS cells)))) (VP (VBZ is) (ADJP-PRD (RB slightly) (JJR lower) (PRN (-LRB- -LRB-) (NP (NML (NML (NML (CD 0.20) (NN %)) (CONJP (RB instead) (IN of)) (NML (CD 0.25) (NN %))) (NN NaCl)) (NN solution)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (ADVP (RB also)) (VP (VBD performed) (NP (NP (JJ direct) (NNS measurements)) (PP (IN of) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN membrane) (NN deformability)))) (, ,) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RBR further)) (VP (VB characterize) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN on) (NP (DT the) (NN membrane) (NN stability)))))))) (. .)) )
( (S (PP-MNR (IN With) (NP (NN micropipette) (NNS experiments))) (NP-SBJ-1 (PRP we)) (VP (VBD tried) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB correlate) (NP (NP (JJ mechanical) (NNS characteristics)) (PP (IN of) (NP (DT the) (JJ red) (NN blood) (NNS cells)))) (PP (IN with) (NP (PRP$ their) (NN morphology))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (MD could) (RB not) (VP (VB observe) (NP (NP (DT any) (ADJP (RB statistically) (JJ significant)) (NN difference)) (PP (IN of) (NP (NP (NNS values)) (VP (VBG describing) (NP (NP (NN membrane) (NN rigidity)) (CC and) (NP (NN lysis) (NN force))))))) (PP (IN in) (NP (DT these) (NNS experiments))) (CIT (-LRB- -LRB-) (NNP M.) (NNP Heil) (, ,) (NNP B.) (NNP Hoffmann) (CC and) (NNP R.) (NNP Merkel) (, ,) (JJ unpublished) (NNS results) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NN distinction)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NML (JJ osmotic) (NN resistance)) (NNS experiments))))) (VP (VP (VBD was) (ADJP-PRD (RB highly) (JJ significant))) (CC and) (VP (VBZ reflects) (NP (NP (DT a) (JJ mean) (NN value)) (PP (IN over) (NP (NP (DT a) (JJ high) (NN number)) (PP (IN of) (NP (JJ different) (JJ red) (NN blood) (NNS cells)))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (CAPTION (NP (NP (NML (JJ Osmotic) (NN resistance)) (NNS curves)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells))) (PP (IN from) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN anxA7) (SYM -) (HYPH /) (SYM -))) (JJ mutant) (NNS mice))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ osmotic) (NN resistance)) (PP (IN towards) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (JJ extracellular) (JJ ionic) (NN strength)))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ convenient) (NN assay)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN integrity))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (PRP It)) (VP (VBZ is) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NP (DT a) (NML (NN sodium) (NN chloride)) (NN concentration)) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ (JJ cellular) (NN lysis)) (VP (VBZ starts) (PP-2 (-NONE- *T*)))))) (PRN (-LRB- -LRB-) (NP (JJ minimal) (NN resistance)) (-RRB- -RRB-)) (PP (IN up) (PP (IN to) (NP (NP (DT a) (JJ complete) (NN lysis)) (PRN (-LRB- -LRB-) (NP (JJ maximal) (NN resistance)) (-RRB- -RRB-)) (PP (IN of) (NP (DT a) (JJ red) (NN blood) (NN cell)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ osmotic) (NN resistance)) (PP (IN of) (NP (ADJP (NP (NN annexin) (NN A7)) (JJ deficient)) (JJ red) (NN blood) (NNS cells)))) (VP (VBZ is) (ADJP-PRD (RB significantly) (JJ increased)) (PP (VBN compared) (PP (IN to) (NP (NP (DT the) (CD one)) (PP (IN of) (NP (JJ wild) (NN type)))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.00066)))) (: ;) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8)))) (-RRB- -RRB-))) (. .))) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ contributes) (PP (IN to) (NP (NP (NP (DT the) (NN shape)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells)))) (CC and) (NP (DT the) (JJ osmotic) (NN resistance)))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (PRP we)) (VP (VBP have) (RB not) (VP (VBN observed) (NP (NP (DT a) (NN binding)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN to) (NP (NN F) (HYPH -) (NN actin)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))))) (NP-SBJ (PRP it)) (VP (MD could) (VP (VB do) (ADVP-PRD (RB so)) (PP-MNR (CC either) (PP (IN by) (NP (NP (NN alteration)) (PP (IN of) (NP (DT the) (NN membrane) (NN rigidity))))) (CONJP (CC and) (HYPH /) (CC or)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG affecting) (NP (DT the) (NN ion) (NN homeostasis)))))))) (. .)) )
( (HEADING (S (NP-SBJ (NP (DT The) (NN lack)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBZ affects) (NP (JJ primary) (NN haemostasis)) (ADVP-LOC (FW ex) (FW vivo))))) )
( (S (NP-SBJ (NP (DT The) (NN use)) (PP (IN of) (NP (NP (DT an) (JJ advanced) (JJ electronic) (NML (NML (NN cell) (NN counter)) (HYPH /) (NML (NN flow) (NN cytometer)))) (-LRB- -LRB-) (NP (NN ADVIA) (CD 120))))) (-RRB- -RRB-) (VP (VBD allowed) (S (NP-SBJ (PRP us)) (VP (TO to) (VP (VB screen) (NP (JJ other) (NNS parameters)) (ADVP (RB as) (RB well)) (PP (IN despite) (X (IN of)) (NP (DT the) (JJ limited) (JJ murine) (NN blood) (NN volume))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD analysed) (NP (NP (NNS leukocytes)) (, ,) (NP (JJ red) (NN blood) (NNS cells)) (, ,) (NP (NN haemoglobin) (NN content)) (, ,) (NP (NN haematocrit)) (, ,) (NP (JJ mean) (JJ cellular) (NN volume)) (, ,) (NP (JJ mean) (JJ cellular) (NN haemoglobin)) (, ,) (NP (NML (JJ mean) (JJ cellular) (NN haemoglobin)) (NN concentration)) (, ,) (NP (NNS platelets)) (, ,) (NP (NNS neutrophiles)) (, ,) (NP (NNS lymphocytes)) (, ,) (NP (NNS monocytes)) (, ,) (NP (NNS eosinophiles)) (CC and) (NP (NNS basophiles)))) (. .)) )
( (S (PP (IN In) (NP (NP (DT these) (NNS tests)) (PP (IN of) (NP (JJ whole) (NN blood))))) (NP-SBJ (PRP we)) (VP (VBD found) (ADVP (RB only)) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (DT the) (NN platelet) (NNS numbers)))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ-1 (DT all) (JJ other) (JJ haematological) (NNS parameters)) (VP (VBD were) (RB not) (VP (VBN affected) (NP-1 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ mean) (NN platelet) (NNS counts)) (PP (IN from) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN anxA7) (SYM -) (HYPH /) (SYM -))) (JJ mutant) (NNS mice)))) (VP (VBP are) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NP (QP (CD 674) (SYM ×) (CD 103))) (PP (SYM /) (NP (NNS μl)))) (CC and) (NP (NP (QP (CD 774) (SYM ×) (CD 103))) (PP (SYM /) (NP (NNS μl)))))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN platelet) (NNS counts)) (PP-LOC (IN in) (NP (NML (NN knock) (NN out)) (NNS mice)))) (VP (VBP are) (ADJP-PRD (RB significantly) (JJR higher) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.0275)))) (: ;) (S-FRM (NP-SBJ (NN n) (NN knock) (NN out)) (VP (SYM =) (NP (CD 11)))) (, ,) (S-FRM (NP-SBJ (NN n) (JJ wild) (NN type)) (VP (SYM =) (NP (CD 14)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT An) (NN increase)) (PP (IN in) (NP (NN platelet) (NNS counts)))) (VP (VBZ is) (NP-PRD (DT a) (ADJP (RB rather) (JJ uncommon)) (NN disorder))) (. .)) )
( (S (PP-LOC (IN In) (NP (NNS humans))) (, ,) (NP-SBJ-1 (NN platelet) (NNS counts)) (ADVP (RB normally)) (VP (VP (VBP increase) (ADVP (RB only) (RB transiently)) (PP (IN as) (NP (PP (IN in) (NP (JJ reactive) (NN thrombocytosis))) (CC and) (PP (IN under) (NP (JJ postoperative) (NNS conditions)))))) (CC or) (VP (VBP are) (ADVP (RB largely)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ neoplastic) (NNS diseases)))))) (. .)) )
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP-SBJ (DT the) (NML (NN anxA7) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBP are) (ADJP-PRD (JJ healthy) (CC and) (JJ viable))) (. .)) )
( (S (ADVP (RB Therefore)) (NP-SBJ (PRP we)) (VP (VP (VBD tested) (NP (DT the) (NN platelet) (NN function))) (CC and) (VP (VBD performed) (NP (NN aggregometry) (NNS measurements)) (PP-MNR (IN with) (NP (ADJP (NN platelet) (JJ rich)) (NN plasma))))) (. .)) )
( (S (NP-SBJ-1 (NN Platelet) (NN activation)) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (JJ morphological) (NN change)) (PP (IN from) (NP (DT the) (VBG resting) (JJ discoid) (NN state))) (PP (IN to) (NP (NP (VBN activated) (JJ spherical) (NNS cells)) (PP (IN with) (NP (NNS pseudopods))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ morphological) (NNS changes)) (VP (VBP are) (PP-PRD (IN due) (IN to) (NP (JJ cytoskeletal) (NNS rearrangements)))) (. .)) )
( (S (ADVP-LOC (FW In) (FW vitro)) (NP-SBJ-1 (DT the) (VBN activated) (NNS cells)) (VP (VBP form) (NP (NNS aggregates)) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VP (VBG recruiting) (NP (JJ additional) (NNS cells)) (PP (IN in) (NP (DT the) (NN solution)))) (VP (ADVP (RB thereby)) (VBG reducing) (NP (PRP$ its) (NN cloudiness)))))) (. .)) )
( (S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN transmission) (NNS values)) (PP (IN of) (NP (NN aggregation) (NNS curves))))) (PP-TMP (IN after) (NP (NP (NN platelet) (NN activation)) (PP (IN by) (NP (NN ristocetin) (NN addition) (PRN (-LRB- -LRB-) (NP (NML (NN von) (NN Willebrand)) (NN cofactor)) (-RRB- -RRB-))))))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (DT both) (NNS curves)) (VP (VBD differed) (ADVP (RB significantly)) (PP-TMP (IN at) (NP (NP (DT the) (NN time) (NN point)) (PP (IN of) (NP (NP (CD seven) (NNS seconds)) (PP (IN after) (NP (NN platelet) (NN initiation))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.0287)))) (, ,) (S-FRM (NP-SBJ (NN n) (NN knock) (NN out)) (VP (SYM =) (NP (CD 16)))) (, ,) (S-FRM (NP-SBJ (NN n) (JJ wild) (NN type)) (VP (SYM =) (NP (CD 15)))) (: ;) (NP (NN Fig.) (CD 6)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (ADJP (NP (NN Annexin) (NN A7)) (JJ deficient)) (NNS platelets)) (VP (VBD showed) (NP (DT a) (ADJP (RB slightly) (VBN lowered)) (NN aggregation) (NN velocity))) (. .)) )
( (S (SBAR-TMP (WHADVP-2 (WRB When)) (S (NP-SBJ (PRP we)) (VP (VBD compared) (NP (NP (DT the) (NN aggregation) (NNS curves)) (PP (IN of) (NP (NP (JJ human) (NNS platelets)) (PP (IN from) (NP (DT a) (JJ healthy) (NN donor)))))) (PP (IN with) (NP (NP (DT the) (NNS ones)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT an) (NN individual)) (PP (IN with) (NP (DT a) (NML (NML (NN von) (NN Willebrand)) (NN factor)) (NML (NN type) (CD 1)) (NN defect)))))))) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN difference)) (PP (IN in) (NP (DT the) (NNS curves)))) (VP (VBD was) (ADJP-PRD (ADVP (RB much) (RBR more)) (JJ pronounced)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (PRP$ our) (NNS studies)) (PP (IN of) (NP (JJ healthy) (NML (NML (NN mouse) (NNS platelets)) (CC and) (NML (NML (NN anxA7) (SYM -) (HYPH /) (SYM -)) (NNS platelets)))))))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (JJ murine) (NNS platelets)) (VP (VBD responded) (ADVP-TMP (RB immediately)) (PP (IN to) (NP (DT the) (VBG initiating) (NN chemical))) (SBAR-ADV (IN whereas) (S (NP-SBJ (JJ human) (NNS platelets)) (VP (VBP have) (NP (DT a) (NN lag) (NN phase)))))))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ]))) (. .)) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (CAPTION (NP (NP (NML (NN Platelet) (NN aggregation)) (NNS curves)) (PP (IN from) (NP (NP (ADJP (NN platelet) (JJ rich)) (NN plasma)) (PP (IN of) (NP (NML (NML (NN annexin) (NN A7)) (NML (NML (NN knock) (NN out)) (CC and) (NML (JJ wild) (NN type)))) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT The) (NN transmission) (NNS values)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT an) (NN APACT) (NN photometer)))))) (CC and) (S (NP-SBJ-2 (NN aggregation)) (VP (VBD was) (VP (VBN initiated) (NP-2 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG adding) (NP (NN ristocetin)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ first) (CD thirty) (NNS seconds)) (VP (VBP are) (VP (VBN given) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Constant) (NN platelet) (NNS counts)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN throughout) (NP (DT all) (NNS experiments))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT The) (NML (NN aggregation) (NN curve)) (NNS data)) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN slope) (NNS values)))))) (, ,) (S (NP-SBJ-2 (NP (DT the) (JJ maximal) (NN aggregation) (NN amplitude)) (PP (IN of) (NP (DT every) (JJ single) (NN curve)))) (VP (VBD was) (VP (VBN set) (NP-2 (-NONE- *)) (PP (IN to) (NP (CD 100) (NN %)))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (DT Both) (JJ murine) (NNS curves)) (VP (VBP differ) (ADVP (RB significantly)) (PP-TMP (IN at) (NP (NP (DT a) (NN time) (NN point)) (PP (IN of) (NP (NP (CD seven) (NNS seconds)) (PP-TMP (IN after) (NP (NN platelet) (NN initiation))))))))) (, ,) (S (NP-SBJ (DT the) (NN mutant)) (VP (VBZ shows) (NP (DT a) (ADJP (RB slightly) (JJR lower)) (NN aggregation) (NN velocity) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.0287)))) (, ,) (S-FRM (NP-SBJ (NN n) (NN knock) (NN out)) (VP (SYM =) (NP (CD 16)))) (, ,) (S-FRM (NP-SBJ (NN n) (JJ wild) (NN type)) (VP (SYM =) (NP (CD 15)))) (, ,) (S-FRM (NP-SBJ (JJ mean) (NN knock) (NN out)) (VP (SYM =) (NP (NML (CD 67.7) (NN %)) (NN transmission)))) (, ,) (S-FRM (NP-SBJ (JJ mean) (JJ wild) (NN type)) (VP (SYM =) (NP (NML (CD 77.1) (NN %)) (NN transmission)))) (, ,) (S-FRM (NP-SBJ (NML (JJ standard) (NN error)) (NN knock) (NN out)) (VP (SYM =) (NP (NML (CD 8.3) (NN %)) (NN transmission)))) (, ,) (S-FRM (NP-SBJ (NML (JJ standard) (NN error)) (JJ wild) (NN type)) (VP (SYM =) (NP (NML (CD 13.8) (NN %)) (NN transmission)))) (-RRB- -RRB-))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Murine) (NNS platelets)) (VP (VP (VBP react) (ADVP-TMP (RB immediately)) (PP (IN to) (NP (DT the) (VBG initiating) (NN chemical)))) (CC and) (VP (VBP show) (NP (DT no) (NN lag) (NN phase)) (PP (IN like) (NP (DT the) (JJ normal) (JJ human) (NNS platelets))))) (. .))) )
( (CAPTION (S (PP-PRP (IN For) (NP (NP (NN comparison)) (PP (IN of) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (DT the) (NN platelet) (NN impairment))))))) (NP-SBJ-1 (ADJP (RB slightly) (VBN affected)) (JJ human) (NNS platelets)) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)) (ADVP (RB as) (RB well)) (PRN (-LRB- -LRB-) (NP (NML (NNP von) (NNP Willebrand)) (NN syndrome)) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ-1 (NN Annexin) (NN A7)) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB have) (NP (DT a) (NN role)) (PP (PP (IN in) (NP (NN vesicle) (NN fusion))) (CC and) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG regulating) (CC and) (VBG stabilizing) (NP (NN membrane) (NNS domains))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NN protein)) (VP (VBZ has) (VP (VBN been) (VP (VBN localized) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN plasma) (NN membrane)) (PP (VBG including) (NP (NN raft) (NNS subdomains))))))))) (, ,) (S (ADVP (RB furthermore)) (NP-SBJ (PRP it)) (VP (VBZ is) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NP (DT the) (NN cytosol)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ-3 (PRP it)) (VP (VBZ is) (VP (VBN found) (NP-3 (-NONE- *)) (PP-LOC (IN on) (NP (JJ subcellular) (ADJP (NN vesicle) (HYPH -) (JJ like)) (NNS structures))) (ADVP-LOC-2 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN distribution)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ independent) (PP (IN of) (NP (NP (DT the) (NML (NN tissue) (CC or) (NN cell)) (NN type)) (VP (VBN analysed) (NP (-NONE- *)))))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (ADJP (ADJP (VBN specialized)) (CC or) (ADJP (RB terminally) (VBN differentiated))) (NNS cells))) (, ,) (S (S (NP-SBJ (NN expression) (NNS levels)) (VP (VBP increase))) (CC and) (S (ADVP-TMP (RB frequently)) (NP-SBJ-1 (NP (DT the) (JJR larger)) (PP (IN of) (NP (DT the) (CD two) (NNS isoforms)))) (VP (VBZ is) (VP (VBG being) (VP (VBN expressed) (NP-1 (-NONE- *)))))) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 34) (, ,) (CD 35)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-2 (NP (JJ Red) (NN blood) (NNS cells)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ devoid) (PP (IN of) (NP (NN annexin) (NN A7)))))))))))) (, ,) (VP (VBD were) (ADVP-TMP (RB recently)) (VP (VBN shown) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB harbor) (NP (NP (DT the) (NML (CD 47) (NN kDa)) (NN isoform)) (PP (ADVP (RB together)) (IN with) (NP (NP (PRP$ its) (VBG binding) (NN partner)) (NP (NN sorcin)))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD showed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NML (CD 51) (NN kDa)) (NN isoform)))) (ADVP (RB as) (RB well)) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG adding) (NP (JJ red) (NN blood) (NNS cells)) (PP (IN to) (NP (NP (DT the) (NN list)) (PP (IN of) (NP (NP (NNS cells)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP harbor) (NP (DT this) (NN isoform)))))))))))) (. .)) )
( (S (S (NP-SBJ (NP (NNP Salzer)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (CONJP (RB not) (RB only)) (VP (VBD demonstrated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN annexin) (NN A7)))) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells))))) (, ,) (S (NP-SBJ (PRP they)) (ADVP (RB also)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (NN annexin) (NN A7)) (CC and) (NP (NN sorcin))) (VP (VBD were) (ADJP-PRD (JJ enriched)) (PP-LOC (IN in) (NP (NP (NML (NN membrane) (NN raft)) (NNS domains)) (PP (IN of) (NP (NP (NNS nanovesicles)) (VP (VBN formed) (NP (-NONE- *)) (PP (IN from) (NP (JJ red) (NN blood) (NNS cells))) (ADVP-LOC (FW in) (FW vitro)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Raft) (NNS domains)) (PP (IN in) (ADJP (JJ general))) (VP (VBP are) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (NP-PRD (NP (JJ key) (NNS players)) (PP (PP (IN in) (NP (NN membrane) (NN organization))) (CC and) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG mediating) (NP (DT the) (NN vesiculation) (NN process)))))))))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VP (VBP result) (PP (IN from) (NP (NP (DT the) (NN clustering)) (PP (IN of) (NP (NNS sphingolipids) (CC and) (NN cholesterol))) (PP-LOC (IN in) (NP (NP (DT the) (JJ outer) (NN leaflet)) (PP (IN of) (NP (NP (DT the) (NN membrane)) (VP (VBN connected) (NP (-NONE- *)) (PP (IN to) (NP (NNS phospholipids) (CC and) (NN cholesterol))) (PP-LOC (IN in) (NP (DT the) (JJ inner) (NN leaflet))))))))))) (CC and) (VP (VBP are) (ADJP-PRD (JJ enriched)) (PP-LOC (IN in) (NP (JJ special) (NN proteins))))) (. .)) )
( (S (ADVP (RB Biochemically)) (NP-SBJ-1 (NNS rafts)) (VP (VP (VBP are) (VP (VBN defined) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NNS membranes)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ resistant) (PP (IN to) (NP (NP (NN extraction)) (PP (IN by) (NP (JJ cold) (NN Triton) (NN X) (HYPH -) (CD 100))))))))))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN floated) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ low) (NNS densities))) (PP (IN in) (NP (NML (NN sucrose) (NN gradient)) (NN centrifugation))) (PRN (-LRB- [) (NP (CD 36)) (-RRB- ])))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS findings) (SBAR-1 (-NONE- *ICH*))) (PP (IN of) (NP (NP (NNP Caohuy)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 37)) (-RRB- ])))) (SBAR-1 (IN that) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ mediates) (NP (NN membrane) (NN aggregation)))))) (ADVP (RB also)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ is) (NP-PRD (DT an) (JJ essential) (NN component)) (PP-TMP (IN during) (NP (NN vesiculation))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (NP-SBJ (PRP they)) (VP (VP (VBD reported) (NP (NP (DT a) (JJ further) (NN activation)) (PP (IN of) (NP (DT the) (NN vesiculation) (NN process))) (PP (IN by) (NP (NN GTP))))) (CC and) (VP (VBD proposed) (SBAR (IN that) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ acts) (PP (IN as) (NP (DT a) (NN GTPase)))))))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (DT the) (NN presence)) (PP (IN of) (NP (NN GTP)))) (VP (VBD enhanced) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NN surfactant))) (PP (IN by) (NP (NN annexin) (NN A7))))) (. .)) )
( (S (S (NP-SBJ-1 (DT These) (NNS results)) (VP (VBD were) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB support) (NP (NP (DT a) (JJ direct) (NN role)) (PP (IN for) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (JJ surfactant) (NN secretion)))))))))) (, ,) (CC but) (S (PP (IN in) (NP (DT these) (NNS studies))) (NP-SBJ-2 (ADJP (NP (NN annexin) (NN A7)) (VBN mediated)) (NN membrane) (NN fusion)) (VP (VBD was) (VP (VBN separated) (NP-2 (-NONE- *)) (PP (IN from) (NP (DT a) (JJ second) (ADJP (NN GTP) (HYPH -) (JJ dependent)) (NN mechanism))) (PRN (-LRB- [) (NP (CD 38)) (-RRB- ]))))) (. .)) )
( (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG Having) (NP (DT an) (NML (NN annexin) (NN A7)) (NN knockout) (NN mouse)))) (NP-SBJ-1 (PRP we)) (VP (VBD tested) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (NP (NN budding)) (PP (IN of) (NP (NML (JJ red) (NN blood) (NN cell)) (NNS vesicles))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN efficiency)) (PP (IN of) (NP (NML (AFX micro) (HYPH -) (CC and) (NN nanovesicle)) (NN formation)))) (VP (VBZ is) (RB not) (ADJP-PRD (RB significantly) (JJ different)) (PP-LOC (IN in) (NP (UCP (NML (JJ wild) (NN type)) (CC and) (ADJP (JJ mutant))) (JJ red) (NN blood) (NNS cells))))))) (. .)) )
( (S (ADVP (RB Likewise)) (, ,) (NP-SBJ (NP (NML (NNP Dictyostelium) (NNP discoideum)) (NNS cells)) (, ,) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (DT the) (JJ single) (NN annexin) (NN gene)) (VP (VBD was) (ADJP-PRD (JJ inactivated)) (PP-1 (-NONE- *T*)))))) (, ,) (VP (VBD were) (RB not) (ADJP-PRD (JJ impaired) (PP (IN in) (NP (NP (NNS processes)) (VP (VBG requiring) (NP (NN membrane) (NN fusion)))))) (PRN (-LRB- [) (-LRB- [) (NP (CD 39)) (-RRB- ]) (: ;) (CC and) (NP (NP (NNS data)) (ADJP (JJ unpublished))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (MD might) (ADVP (RB well)) (VP (VB be) (SBAR-PRD (IN that) (S (NP-SBJ-1 (NP (DT the) (VBN observed) (NN fusion)) (PP (IN of) (NP (NN phospholipid) (NNS layers))) (PP (IN by) (NP (NN annexin) (NN A7))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ high) (NN Ca2+) (NNS concentrations)))))) (VP (MD may) (VP (VB turn) (PRT (RP out)) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (DT an) (ADJP (FW in) (FW vitro)) (NN effect))))))))))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ (NP (DT the) (JJ high) (NN abundance)) (PP (IN of) (NP (NN annexin) (NN A7))) (PP-LOC (IN in) (NP (AFX micro) (HYPH -) (CC and) (NNS nanovesicles)))) (VP (MD might) (VP (VB be) (ADJP-PRD (JJ fortuitous)) (SBAR-ADV (IN as) (S (NP-SBJ (NP (DT a) (JJ significant) (NN percentage)) (PP (IN of) (NP (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN membrane)) (, ,) (SBAR (WHPP-1 (IN with) (WHNP (WDT which))) (S (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ associates) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (DT the) (NN Ca2+) (NNS levels)) (VP (VBP rise) (ADVP-TMP-2 (-NONE- *T*))))) (PP-1 (-NONE- *T*)))))))) (, ,) (VP (VBZ appears) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN involved) (NP-3 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NNS exovesicles)))))))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (DT the) (NN distribution)) (PP (IN of) (NP (DT both) (NML (NN annexin) (NN A7)) (NNS isoforms))) (PP (IN in) (NP (NP (NNS gradients)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells)))))) (VP (VBZ indicates) (NP (NP (DT a) (NN function)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ differs) (PP (IN from) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG organizing) (NP (NP (JJ subcellular) (NNS membranes)) (CC or) (NP (NN membrane) (NNS pathways))))))))))) (. .)) )
( (S (SBAR-ADV (IN Whereas) (S (NP-SBJ-1 (NN annexin) (NN A2)) (VP (VBZ is) (VP (VP (ADVP (RB tightly)) (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NNS endosomes)))) (CC and) (VP (MD may) (VP (VB have) (NP (NNS functions)) (PP (IN in) (NP (NP (NN membrane) (NN fusion)) (CC and) (NP (DT the) (JJ endosomal) (NN pathway)))))))))) (, ,) (NP-SBJ (NN annexin) (NN A7)) (VP (VBZ distributes) (PP (IN with) (NP (NP (NML (NN plasma) (NN membrane)) (NN raft) (NNS domains)) (PP (IN of) (NP (JJ different) (NML (NNS types) (CC and) (NNS densities))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (PP-LOC (IN in) (NP (NP (NNS vesicles)) (PP (IN of) (NP (NP (JJ red) (NN blood) (NNS cells)) (VP (VBG lacking) (NP (NN annexin) (NN A7))))))) (NP-SBJ-2 (NP (DT the) (NN amount)) (PP (IN of) (NP (NN sorcin)))) (VP (VBZ is) (VP (VBN lowered) (NP-2 (-NONE- *)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (S (NP-SBJ-1 (PRP$ its) (NN localisation)) (VP (VBZ is) (VP (VBN affected) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN loss)) (PP (IN of) (NP (NN annexin) (NN A7)))))))) (CC or) (S (NP-SBJ-3 (NP (PRP$ its) (NN expression)) (PP-TMP (IN during) (NP (NML (JJ red) (NN blood) (NN cell)) (NN development)))) (VP (VBD was) (VP (VBN reduced) (NP-3 (-NONE- *))))))))))) (. .)) )
( (S (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG Having) (VP (VBN excluded) (NP (NP (DT a) (JJ direct) (NN role)) (PP (IN in) (NP (NP (NN vesicle) (NN formation)) (CC and) (NP (NN membrane) (NN fusion)))))))) (, ,) (NP-SBJ-1 (NN annexin) (NN A7)) (VP (MD might) (VP (VB act) (PP-MNR (IN by) (NP (NP (PRP$ its) (NN property)) (PP (IN as) (NP (ADJP (NN Ca2+) (HYPH -) (VBG binding)) (NN protein))))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-2 (NP (JJ Previous) (NNS results)) (SBAR (WHPP-4 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NN annexin) (NN A7)) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN membrane) (NN aggregation)))))) (PP-4 (-NONE- *T*))))))) (VP (MD might) (VP (VB be) (VP (VBN explained) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (JJ supportive) (NN function)) (PP (IN of) (NP (NN annexin) (NN A7))))) (SBAR-ADV (IN in) (IN that) (S (NP-SBJ-3 (PRP it)) (VP (VBZ interferes) (PP (IN with) (NP (DT the) (JJ local) (NN Ca2+) (NN homeostasis))) (S-ADV (NP-SBJ-3 (-NONE- *PRO*)) (ADVP (RB thus)) (VP (VBG influencing) (NP (NN membrane) (NN organization)))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (DT the) (NNS annexins)) (VP (VBP belong) (PP (IN to) (NP (DT a) (ADJP (ADJP (RB wide) (VBN spread)) (CC and) (ADJP (RB evolutionarily) (VBN conserved))) (NN protein) (NN family)))))) (, ,) (NP-SBJ-1 (ADJP (NN redundant) (, ,) (CONJP (CC but) (RB not)) (JJ identical)) (NNS functions)) (VP (VBP are) (VP (VBN expected) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (ADVP-TMP (RB so) (RB far)) (NP-SBJ-2 (NP (DT no) (JJ other) (NNS members)) (PP (IN of) (NP (NP (DT the) (NN annexin) (NN family)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB substitute) (PP (IN for) (NP (NN annexin) (NN A7)))))))))) (, ,) (VP (VBP have) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (JJ red) (NN blood) (NNS cells)))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ structural) (NN basis)) (PP (IN for) (NP (NP (DT the) (NN elasticy)) (PP (IN of) (NP (NP (JJ red) (NN blood) (NNS cells)) (PP (IN in) (NP (NN circulation)))))))) (VP (VBP are) (NP-PRD (NP (NML (JJ long) (NN range)) (JJ molecular) (NNS functions)) (PP (IN of) (NP (NP (DT the) (NN plasma) (NN membrane)) (CC and) (NP (NP (DT the) (ADJP (NN membrane) (VBN associated)) (NN part)) (PP (IN of) (NP (DT the) (NN cytoskeleton))))))) (PRN (-LRB- [) (NP (NP (CD 40)) (PP (SYM -) (NP (CD 43)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (JJ Major) (NNS constituents)) (PP (IN of) (NP (DT the) (NN membrane) (NN skeleton)))) (VP (VBP are) (NP-PRD (NP (NN spectrin) (NNS tetramers)) (VP (VBN linked) (NP (-NONE- *)) (ADVP (RB together)) (PP (IN by) (NP-LGS (NP (JJ short) (NN actin) (NNS filaments)) (CC and) (NP (NP (JJ several) (JJ other) (NN proteins)) (VP (VBG covering) (NP (NP (DT the) (JJ entire) (JJ cytoplasmic) (NN surface)) (PP (IN of) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN membrane)))))))))) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NN Membrane) (NN cholesterol)) (VP (VBZ diminishes) (NP (NP (NML (JJ red) (NN blood) (NN cell)) (NN haemolysis)) (PP (IN by) (NP (DT the) (NN complement) (NN complex)))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (NP (NN depletion)) (PP (IN of) (NP (NN raft) (NN cholesterol)))) (VP (VBZ abrogates) (NP (NP (NN association)) (PP (IN of) (NP (DT all) (NN raft) (NN proteins)))) (PP (IN with) (NP (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (NP (NNS areas)) (PP (IN in) (NP (NP (DT the) (NN rest)) (PP (IN of) (NP (DT the) (NN cell) (NN membrane)))))) (CC and) (NP (NN deformability))))))))) (PRN (-LRB- [) (NP (CD 45) (, ,) (CD 46)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NML (NN Annexin) (NN A7)) (NML (NML (NN knock) (NN out)) (NN mouse)) (JJ red) (NN blood) (NNS cells)) (VP (VP (VBP show) (NP (DT a) (ADJP (RBR more) (JJ flat)) (NN shape))) (CC and) (VP (VBP have) (NP (DT a) (JJR higher) (JJ osmotic) (NN resistance)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN presence)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (MD may) (VP (VB alter) (NP (DT the) (NN membrane) (NN flexibility)) (SBAR-ADV (IN in) (IN that) (S (NP-SBJ (PRP it)) (VP (VP (VBZ supports) (NP (DT the) (JJ typical) (NN biconcave) (NN membrane) (NN shape))) (CC and) (VP (VBZ leads) (PP (IN to) (NP (DT a) (JJR lower) (JJ minimal) (JJ osmotic) (NN resistance))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Annexin) (NN A7)) (VP (VBZ does) (RB not) (VP (VB appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB have) (NP (NP (DT an) (NN influence)) (PP (IN on) (NP (NP (NML (NN plasma) (NN membrane)) (NN integrity)) (NP (PRP itself))))) (SBAR-ADV (IN as) (S (NP-SBJ (DT the) (JJ maximal) (NML (JJ osmotic) (NN resistance)) (NN value)) (VP (VBZ stays) (ADJP-PRD (JJ constant)))))))))) (. .)) )
( (S (NP-SBJ-1 (UCP (NML (NN Ca2+)) (CC and) (ADJP (NN membrane) (JJ skeletal))) (NN proteins)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB play) (NP (JJ key) (NNS roles)) (PP (IN on) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN membrane) (NML (NN shape) (CC and) (NN stability))))))) (PRN (-LRB- [) (NP (CD 47)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Annexins)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB bind) (ADVP-MNR (RB directly)) (PP (IN to) (NP (NN F) (HYPH -) (NN actin)))))))))) (, ,) (S (NP-SBJ (PRP we)) (VP (MD could) (ADVP (RB however)) (VP (VB exclude) (NP (JJ such) (DT an) (NN activity)) (PP (IN for) (NP (NN annexin) (NN A7)))))) (. .)) )
( (S (ADVP (RB Nevertheless)) (NP-SBJ-1 (PRP it)) (VP (MD might) (VP (VP (VP (VB interact) (PP (IN with) (NP (JJ other) (NNS components)))) (CC and) (VP (VBP have) (NP (DT a) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG organizing) (NP (DT the) (NN membrane) (NN cytoskeleton))))))) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VP (VP (VBG controlling) (NP (NML (NN raft) (NN protein)) (NNS associations))) (CC or) (VP (VBG influencing) (NP (NP (DT the) (JJ ionic) (NN strength)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells)))))) (PP-MNR (PP (IN on) (NP (PRP$ its) (JJ own))) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG interfering) (PP (IN with) (NP (JJ other) (NN signaling) (NNS pathways))))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN discussed) (NP-1 (-NONE- *)) (ADVP (RB above))))) (NP-SBJ-2 (NN annexin) (NN A7)) (VP (MD could) (VP (VB be) (VP (VBN involved) (NP-2 (-NONE- *)) (PP (IN in) (NP (DT the) (NML (JJ cytoplasmic) (NN Ca2+)) (NN homeostasis)))))) (. .)) )
( (S (NP-SBJ-3 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (NP-3 (-NONE- *)) (SBAR-1 (IN that) (S (NP-SBJ (NP (JJ micromolar) (NNS changes)) (PP (IN of) (NP (DT the) (JJ intracellular) (NN Ca2+) (NN concentration)))) (VP (VBP exert) (NP (NP (DT a) (JJ profound) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN membrane) (NNS properties)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP regulate) (NP (NML (JJ red) (NN blood) (NN cell)) (NN deformability))))))))))) (PRN (-LRB- [) (NP (CD 48) (, ,) (CD 49)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-1 (DT the) (JJ intracellular) (NN Ca2+)) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB regulate) (NP (DT the) (NN membrane) (NN stability)) (PP-MNR (IN through) (NP (NP (NN modulation)) (PP (IN of) (NP (NML (JJ cytoskeletal) (NN protein)) (NNS interactions)))))))) (PRN (-LRB- [) (NP (CD 50)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NN Ca2+)) (ADVP (RB also)) (VP (VBZ induces) (NP (NP (DT a) (NN transbilayer) (NN phospholipid) (NN redistribution)) (VP (VBG inducing) (NP (NP (DT a) (NN shape) (NN change)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells)))))) (PRN (-LRB- [) (NP (CD 51)) (-RRB- ]))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NN Ca2+) (NNS ions)) (VP (MD can) (VP (VB drive) (NP (NP (NN spiculation)) (PP (IN of) (NP (DT the) (NN membrane) (NN bilayer)))) (PP-MNR (IN without) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG involving) (NP (DT the) (NN cytoskeleton))))) (PRN (-LRB- [) (NP (CD 52)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN observed) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (NN platelet) (NN function)))) (PP-LOC (IN in) (NP (DT the) (NML (NN annexin) (NN A7)) (NN mutant))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (NML (NN platelet) (NN aggregation)) (NNS experiments))) (NP-SBJ (DT the) (JJ initial) (NN aggregation) (NN velocity)) (VP (VBD was) (ADJP-PRD (ADVP (RB slightly) (, ,) (CC but) (RB significantly)) (JJR lower)) (PP-LOC (IN in) (NP (NP (NNS platelets)) (VP (VBG lacking) (NP (NN annexin) (NN A7)))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS data)) (VP (VBP are) (RB not) (VP (VBN reflected) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN change)) (PP (IN in) (NP (DT the) (ADJP (FW in) (FW vivo)) (NN bleeding) (NN time))))))) (. .)) )
( (S (S (ADVP (RB However)) (NP-SBJ (NP (DT the) (NN reaction) (NN speed)) (PP (IN of) (NP (JJ murine) (NNS platelets)))) (VP (VBZ is) (ADJP-PRD (ADJP (RB much) (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (JJ human)))))))) (CC and) (S (PP-PRP (IN due) (IN to) (NP (DT the) (JJ technical) (NN setup))) (NP-SBJ (PRP we)) (VP (MD might) (VP (VB have) (VP (VBN missed) (NP (JJR larger) (NNS changes)) (PP-LOC (IN in) (NP (DT the) (NN mouse) (NNS samples))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT The) (JJ immediate) (NN reaction)) (PP (IN of) (NP (NN mouse) (NNS platelets)))) (CC and) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT a) (NN lag) (NN phase)) (PP-TMP (IN after) (NP (NN triggering))))))) (VP (MD may) (VP (VB be) (VP (VBN caused) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT an) (ADJP (RB immediately) (VBN initiated)) (NN thrombin) (NN generation))) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ]))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN known) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (JJ frequent) (JJ human) (NN vWF) (HYPH -) (NN syndrome)) (CC or) (NP (JJ other) (JJ haemostatic) (NNS diseases))))))) (, ,) (NP-SBJ (JJ small) (NNS defects)) (ADVP-TMP (RB often)) (VP (VP (VP (VBP are) (ADJP-PRD (RB clinically) (JJ silent))) (CC and) (VP (VBP do) (RB not) (VP (VB result) (PP (IN in) (NP (JJ physiological) (NNS changes)))))) (PP (IN under) (NP (JJ normal) (NNS conditions)))) (. .)) )
( (S (PP (ADVP (RB Only)) (IN in) (NP (NP (NNS situations)) (PP (IN with) (NP (JJ severe) (JJ physical) (NN injury))))) (, ,) (NP-SBJ (NP (JJ distinct) (JJ environmental) (NNS influences)) (CC or) (NP (NP (JJ additional) (NN platelet) (VBZ attributes)) (PP (IN like) (NP (DT the) (NML (NN platelet) (NN antigen)) (NN polymorphism) (PRN (-LRB- [) (NP (CD 53)) (-RRB- ])) (NNS differences))))) (VP (MD might) (VP (VB become) (ADJP-PRD (JJ apparent)))) (. .)) )
( (HEADING (NP (NNS Conclusions))) )
( (S (PP (IN In) (NP (DT this) (NN paper))) (NP-SBJ (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (CC both) (NML (NN annexin) (NN A7)) (NNS isoforms))) (PP-LOC (IN in) (NP (NP (JJ red) (NN blood) (NNS cells)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (PRP they)) (VP (VBP are) (ADJP-PRD (JJ abundant)) (PP-LOC (IN in) (NP (NP (NNS nanovesicles)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP form) (PP-TMP (IN upon) (NP (NN Ca2+) (NN addition)))))))) (ADVP-LOC-2 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN proteins)) (VP (VBP are) (ADVP (RB however)) (RB not) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (DT the) (NN vesiculation) (NN process))))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VBP are) (ADVP (RB also)) (RB not) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (JJ specific) (NN membrane) (NNS domains)) (PP (JJ such) (IN as) (NP (NN lipid) (NNS rafts)))))))) (, ,) (PP (IN as) (NP (NP (NP (ADJP (RB exogenously) (VBN added)) (JJ recombinant) (NN annexin) (NN A7)) (VP (VBN redistributed) (NP (-NONE- *)) (PP (IN to) (NP (JJ similar) (NNS positions))))) (PP (IN in) (NP (NP (DT a) (NN density) (NN gradient)) (VP (VBG containing) (NP (NP (NNS membranes)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (JJ red) (NN blood) (NNS cells)) (PP (IN of) (NP (NML (NN anxA7) (SYM -) (HYPH /) (SYM -)) (NNS mice))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (VBN observed) (NML (NN cell) (NN shape)) (NN change)) (PP (IN of) (NP (NP (NNS erythrocytes)) (VP (VBG lacking) (NP (NN annexin) (NN A7)))))) (VP (MD might) (VP (VB be) (PP-PRD (IN due) (IN to) (NP (NP (NNS alterations)) (PP-LOC (IN in) (NP (DT the) (NN erythrocyte) (NN cytoskeleton))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (NP (DT a) (JJ direct) (NN interaction)) (PP (IN with) (NP (NN F) (HYPH -) (NN actin)))) (VP (VBD was) (VP (VBN ruled) (NP-1 (-NONE- *)) (PRT (RP out)))))) (, ,) (NP-SBJ-2 (DT this) (NN effect)) (VP (MD might) (VP (VB be) (VP (VBN mediated) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN annexin) (POS 's)) (ADJP (NN Ca2+) (HYPH -) (VBG binding)) (NN activity)))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (HEADING (NP (NP (NN Acquisition)) (PP (IN of) (NP (NML (NML (JJ murine) (CC and) (JJ human)) (NN blood)) (NNS samples))))) )
( (S (NP-SBJ-1 (NP (NP (NN Blood)) (PP (IN from) (NP (NN 129Sv) (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN annexin) (NN A7))) (NML (NN knock) (NN out)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN anxA7) (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-))))) (VP (VP (VBN kept) (NP (-NONE- *)) (PP (IN under) (NP (ADJP (NN pathogen) (HYPH -) (JJ free)) (NNS conditions)))) (CC and) (VP (VBN fed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (JJ regular) (NN food)))))) (, ,) (VP (VBD was) (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 1) (NN ml)) (NNS syringes))) (PP-MNR (IN with) (S-NOM (NP-SBJ (DT a) (NML (CD 22) (NN gauge)) (NN needle)) (VP (VBG punctating) (NP (DT the) (JJ right) (JJ cardiac) (NN ventricle)) (SBAR-ADV (ADVP (RB immediately)) (IN after) (S (NP-SBJ-2 (PRP they)) (VP (VBD had) (VP (VBN been) (VP (VBN killed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (JJ cervical) (NN dislocation))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Coagulation)) (ADVP (RB generally)) (VP (VBD was) (VP (VBN inhibited) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NP (QP (CD 1) (SYM /) (CD 10)) (NN volume)) (PP (IN of) (NP (NP (NML (CD 10) (NN mM)) (NN NaEDTA)) (, ,) (NP-ADV (NN pH) (CD 7.5))))) (, ,) (RRC (ADVP (RB already)) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT the) (NN syringe)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS mice)) (VP (VBD were) (VP (VBN killed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ cervical) (NN dislocation))) (PP (IN in) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB avoid) (NP (NP (DT any) (NN effect)) (PP (IN of) (NP (JJ anaesthetic) (NNS chemicals))) (PP (IN on) (NP (NN blood) (NNS parameters))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (UCP (NML (JJ wild) (NN type)) (CC and) (ADJP (JJ mutant))) (NNS mice)) (VP (VBD were) (VP (VBN matched) (NP-1 (-NONE- *)) (PP-MNR (VBG regarding) (NP (PRP$ their) (NML (NN age) (, ,) (NN weight) (CC and) (NN sex)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT The) (NN daytime)) (PP (IN of) (NP (NN blood) (NN collection)))) (, ,) (NP (VBG sampling) (NN site)) (CC and) (NP (NN collection) (NN method))) (VP (VBD were) (VP (VBN kept) (NP-1 (-NONE- *)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (JJ constant))) (PP-TMP (IN during) (NP (DT all) (NNS experiments))))) (. .)) )
( (S (NP-SBJ (DT A) (JJ typical) (NML (JJ murine) (NN blood) (NN sample)) (NN volume)) (VP (VBD consisted) (PP (IN of) (NP (CD 550) (NN μl))) (, ,) (PP (IN with) (NP (NP (NNS variations)) (VP (VBG ranging) (PP (PP (IN from) (NP (CD 200) (NNS μl))) (PP (IN to) (NP (CD 900) (NNS μl)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Human) (NN blood) (NNS samples)) (PP (IN from) (NP (DT the) (NNS authors)))) (VP (VBD were) (VP (VBN collected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN vein) (NN puncture))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ common) (NN EDTA) (HYPH -) (NNS monovettes)))) (PRN (-LRB- -LRB-) (NP (NNP Sarstedt)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD performed) (NP (PRP$ our) (NNS studies)) (S-MNR (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG using) (NP (ADJP (RB well) (JJ standardized)) (NN sampling) (NNS conditions)))) (, ,) (SBAR-PRP (IN as) (S (NP-SBJ (NP (NNS differences)) (PP (IN in) (NP (DT the) (NML (NN blood) (NN sampling)) (NN site))) (, ,) (PP (PP (IN for) (NP (NN example))) (IN between) (NP (NN tail) (CC and) (NN heart)))) (, ,) (VP (VBP show) (NP (NP (JJ large) (NNS changes)) (PP (IN in) (NP (DT all) (NML (NN cell) (NN type)) (NNS counts)))))))) (. .)) )
( (S (NP-SBJ (ADJP (JJ First) (CC and) (JJ second)) (NN sample) (NN draw)) (VP (VBP affect) (NP (NN blood) (NNS measurements)) (, ,) (ADVP (RB too)) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Also)) (NP-SBJ (NP (DT the) (JJ genetic) (NN background)) (PP-LOC (IN in) (NP (JJ common) (UCP (NN laboratory) (CC and) (JJ transgenic)) (NNS mice)))) (VP (VBZ affects) (NP (DT the) (NN phenotype))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN change)) (PP (IN from) (NP (CD one) (NN strain))) (PP (IN to) (NP (DT another)))) (VP (MD may) (VP (VB protect) (NP (NNS mice)) (PP (IN from) (NP (NP (NNS effects)) (PP (IN of) (NP (DT the) (ADJP (RB primarily) (VBN induced)) (JJ genetic) (NN defect))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NML (NN BALB) (HYPH /) (NN c)) (NNS mice)) (VP (VBP have) (NP (NP (DT a) (ADJP (RB significantly) (VBN increased)) (NN velocity)) (PP (IN of) (NP (NN platelet) (NN aggregation)))) (PP (IN as) (PP (VBN compared) (PP (IN to) (NP (NP (NN 129Sv) (NNS mice)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-TMP (IN throughout) (NP (DT this) (NN study))))))))))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ]))) (. .)) )
( (HEADING (NP (NP (ADJP (NN Self) (VBG forming)) (NN iodixanol) (NN density) (NNS gradients)) (PP (IN of) (NP (JJ human) (JJ red) (NN blood) (NNS cells))))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ subcellular) (NN distribution)) (PP (IN of) (NP (NN annexin) (NN A7)))) (VP (VBD was) (VP (VBN addressed) (NP-1 (-NONE- *)) (PP (VBG according) (PP (IN to) (-LRB- [) (NP (CD 24)))))) (-RRB- ]) (. .)) )
( (S (NP-SBJ-1 (JJ Red) (NN blood) (NNS cells)) (VP (VBD were) (VP (VP (VBN centrifuged) (NP-1 (-NONE- *))) (CC and) (VP (VBN washed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (JJ isotonic) (NML (VBN buffered) (NN salt)) (NN solution)))) (, ,) (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN in) (NP (ADJP (NN ice) (JJ cold)) (NN lysis) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 20) (NN mM)) (NN Hepes)) (, ,) (NP-ADV (NN pH) (CD 7.4))) (, ,) (NP (NML (CD 200) (NN μM)) (NN CaCl2)) (, ,) (NP (NML (CD 0.25) (NN M)) (NN sucrose)) (, ,) (CC and) (NP (NN proteinase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP Roche)) (-RRB- -RRB-)) (-RRB- -RRB-))))) (, ,) (VP (VBN homogenized) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (ADJP (RB loosely) (JJ fitting)) (NN dounce) (NN homogenizer)) (CC and) (NP (NP (JJ additional) (NNS passages)) (PP (IN through) (NP (DT a) (NML (CD 22) (NN gauge)) (NN needle))))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (NML (CD 50) (NN %)) (NN iodixanol) (NN solution)) (VP (VBD was) (VP (VBN established) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG mixing) (NP (NN Optiprep) (NN solution) (PRN (-LRB- -LRB-) (NP (NML (CD 60) (NN %)) (NN iodixanol)) (: ;) (NP (NN Sigma)) (-RRB- -RRB-))) (PP (IN with) (NP (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 120) (NN mM)) (NN Hepes)) (, ,) (NP-ADV (NN pH) (CD 7.4))) (, ,) (NP (NML (CD 1.2) (NN mM)) (NN CaCl2)) (, ,) (NP (NML (CD 0.25) (NN M)) (NN sucrose)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (CD Seven) (NNS parts)) (PP (IN of) (NP (DT this) (NML (CD 50) (NN %)) (NN iodixanol) (NN solution)))) (VP (VBD were) (VP (VBN mixed) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (CD thirteen) (NNS parts)) (PP (IN of) (NP (DT the) (NML (JJ red) (NN blood) (NN cell)) (NN solution))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG generating) (NP (NP (DT a) (NN gradient) (NN solution)) (VP (VBG containing) (NP (NML (CD 17.5) (NN %)) (NN iodixanol)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN mixture)) (VP (VBD was) (VP (VP (VP (VBN filled) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (DT a) (JJ centrifuge) (NN tube)) (ADJP (VBN underlayed) (PP (IN by) (NP (NP (NNS cushions)) (PP (IN of) (NP (NML (NML (CD 30) (NN %)) (CC and) (NML (CD 35) (NN %))) (NN iodixanol))))))))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 3) (NNS hours))) (PP (IN at) (NP (CD 270,000) (SYM ×) (NN g))) (PP (IN in) (NP (DT a) (NML (NN SW41) (NNP Ti)) (NML (NN swing) (NN out)) (NN rotor) (PRN (-LRB- -LRB-) (NP (NN Beckman)) (-RRB- -RRB-)))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB achieve) (NP (DT a) (ADJP (RB nearly) (JJ linear)) (NN density) (NN gradient) (PRN (-LRB- -LRB-) (NP (ADVP (RB approximately)) (NP (CD 1.06) (NNS g)) (PP (SYM /) (NP (NN ml))) (PP (IN to) (NP (NP (CD 1.20) (NNS g)) (PP (SYM /) (NP (NN ml)))))) (-RRB- -RRB-)))))) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Fractions)) (PP (IN of) (NP (CD 0.6) (NN ml)))) (VP (VBD were) (VP (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN top)) (PP (IN of) (NP (DT the) (NN gradient))))) (PP-MNR (IN by) (NP (DT a) (NML (CD 1) (NN ml)) (NN syringe))) (PP-MNR (IN without) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NN needle)))))) (CC and) (VP (ADVP-TMP (RB immediately)) (VBN frozen) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (JJ liquid) (NN nitrogen))) (PP-PRP (IN for) (NP (JJ further) (NN use)))))) (. .)) )
( (HEADING (NP (NP (NN Exovesicle) (NN generation)) (PP (IN from) (NP (ADJP (JJ human) (CC and) (JJ murine)) (JJ red) (NN blood) (NNS cells))))) )
( (S (NP-SBJ (JJ Red) (NN blood) (NNS cells)) (ADVP (RB naturally)) (VP (MD can) (VP (VB form) (NP (ADJP (NN hemoglobin) (VBG containing)) (NNS exovesicles)))) (. .)) )
( (S (ADVP-LOC (FW In) (FW vitro)) (NP-SBJ (DT these) (NN vesicle) (NN formation)) (VP (VBZ is) (ADJP-PRD (NN Ca2+) (VBN induced))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Freshly) (VBN collected)) (NML (NN lithium) (HYPH -) (NN heparin)) (VBN anticoagulated) (NN blood) (NNS samples)) (VP (VBD were) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 5) (NNS minutes))) (PP (IN at) (NP (NP (CD 400) (SYM ×) (NN g)) (CC and) (NP (CD 4) (NN °C)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS erythrocytes)) (VP (VBD were) (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (CD five) (NNS times)) (PP-MNR (IN with) (NP (NP (NP (NML (CD 20) (NN mM)) (NN Hepes)) (, ,) (NP-ADV (NN pH) (CD 7.5))) (, ,) (CC and) (NP (NML (CD 150) (NN mM)) (NN NaCl) (PRN (-LRB- -LRB-) (NP (VBG washing) (NN buffer)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN volume)) (PP (IN of) (NP (NML (CD 500) (NN μl)) (VBN washed) (JJ red) (NN blood) (NNS cells)))) (VP (VBD were) (VP (VP (VBN combined) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (CD 3) (NN ml)) (PP (IN of) (NP (NN vesiculation) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 20) (NN mM)) (NN Hepes)) (, ,) (NP-ADV (NN pH) (CD 7.5))) (, ,) (NP (NML (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (NP (NML (CD 1) (NN mM)) (NN CaCl2)) (VP (VBN adjusted) (NP (-NONE- *)) (PP (IN to) (NP (NML (CD 5) (NN μM)) (NN Ca2+) (NN ionophore) (NN A23187))))) (-RRB- -RRB-))))))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 30) (NNS minutes))) (PP (IN at) (NP (CD 37) (NNS °C)))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NN incubation))) (NP-SBJ-1 (NN EDTA)) (VP (VBD was) (VP (VP (VBN added) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NN solution))) (PP (IN to) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (CD 5) (NN mM)))))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 5) (NNS minutes))) (PP (IN at) (NP (NP (CD 400) (SYM ×) (NN g)) (CC and) (NP (CD 4) (NNS °C))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN supernatant)) (VP (VBD was) (VP (VP (VBN collected) (NP-1 (-NONE- *))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 20) (NNS minutes))) (PP (IN at) (NP (NP (CD 15,000) (SYM ×) (NN g)) (CC and) (NP (CD 4) (NNS °C))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBG resulting) (NN pellet)) (VP (VBD was) (VP (VP (VP (VBN resuspended) (NP-1 (-NONE- *)) (PP (IN in) (NP (VBG washing) (NN buffer)))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 400) (SYM ×) (NN g))) (ADVP-TMP (RB again)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB collect) (NP (NP (DT a) (NN supernatant)) (VP (VBN enriched) (NP (-NONE- *)) (PP (IN with) (NP (NML (JJ red) (NN blood) (NN cell)) (NNS microvesicles)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN supernatant)) (PP (IN of) (NP (DT the) (NML (CD 15,000) (SYM ×) (NN g)) (NN step)))) (VP (VBD was) (ADVP (RBR further)) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 60) (NNS minutes))) (PP (IN at) (NP (NP (CD 100,000) (SYM ×) (NN g)) (CC and) (NP (CD 4) (NNS °C)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ final) (NN pellet)) (PP (IN of) (NP (DT this) (NN step)))) (VP (VBD was) (VP (VP (VP (VBN resuspended) (NP-1 (-NONE- *)) (PP (IN in) (NP (VBG washing) (NN buffer)))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 15,000) (SYM ×) (NN g))) (ADVP-TMP (RB again)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB purify) (NP (NP (DT a) (NN supernatant)) (VP (VBN enriched) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NNS nanovesicles))))) (PP (VBG according) (PP (IN to) (-LRB- [) (NP (CD 7) (, ,) (CD 20)))))))) (-RRB- ])) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS vesicles)) (VP (VBD were) (VP (VP (VBN assayed) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NN acetylcholine) (NN esterase)) (NN activity)))) (CC and) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ further) (NN analysis)))))) (. .)) )
( (HEADING (NP (NML (NN Acetylcholine) (NN esterase)) (NN assay))) )
( (S (NP-SBJ-1 (NP (DT A) (NML (CD 30) (NN μl)) (NN sample)) (PP (IN of) (NP (NML (JJ red) (NN blood) (NN cell)) (NNS vesicles)))) (VP (VBD was) (VP (VP (VBN mixed) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT an) (JJ equal) (NN volume)) (PP (IN of) (NP (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 20) (NN mM)) (NN Hepes)) (, ,) (NP-ADV (NN pH) (CD 7.6))) (, ,) (NP (NML (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (NML (CD 0.5) (NN %)) (NN Triton) (NN X) (HYPH -) (CD 100)) (-RRB- -RRB-))))))) (, ,) (VP (VBN vortexed) (NP-1 (-NONE- *))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 5) (NNS minutes))) (PP (IN at) (NP (CD 37) (NNS °C)))))) (. .)) )
( (S (ADVP-TMP (RB Subsequently)) (NP-SBJ-1 (NP (NML (CD 640) (NN μl)) (NML (NN sodium) (NN phosphate)) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 100) (NN mM)) (NN Na2PO4)) (, ,) (NP-ADV (NN pH) (CD 7.6))) (-RRB- -RRB-))) (, ,) (NP (NML (CD 50) (NN μl)) (NN DTNB) (PRN (-LRB- -LRB-) (NP (CD 5) (, ,) (NML (CD 5) (SYM ')) (HYPH -) (NN dithiobis)) (HYPH -) (PRN (-LRB- -LRB-) (NP (CD 2) (HYPH -) (JJ nitrobenzoic) (NN acid)) (-RRB- -RRB-)) (, ,) (NP (NP (CD 10) (NN mM)) (PP (IN in) (NP (NML (NN sodium) (NN phosphate)) (NN buffer)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NML (CD 50) (NN μl)) (NN acetylthiocholine) (NN chloride) (PRN (-LRB- -LRB-) (NP (NP (CD 12) (, ,) (CD 5) (NN mM)) (PP (IN in) (NP (NN H2O)))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN added) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN reaction)) (VP (VP (VBD took) (NP (NN place)) (PP (IN at) (NP (NN room) (NN temperature)))) (CC and) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (ADVP-MNR (RB photometrically)) (PP-MNR (IN at) (NP (NP (DT a) (NN wavelength)) (PP (IN of) (NP (CD 405) (NNS nm))))) (PP-MNR (VBG according) (PP (IN to) (NP (DT the) (NNP Ellmann) (POS ') (NN method)))) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))))) (. .)) )
( (HEADING (NP (NP (NN Determination)) (PP (IN of) (NP (NP (DT the) (JJ osmotic) (NN resistance)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells))))))) )
( (S (NP-SBJ-1 (NP (NP (DT A) (ADJP (NP (NN Na2HPO4) (HYPH /) (NN NaH2PO4)) (VBN buffered)) (NN NaCl) (NN gradient)) (NP-ADV (-LRB- -LRB-) (NN pH) (CD 7.4) (-RRB- -RRB-))) (VP (VBN comprised) (NP (-NONE- *)) (PP (IN of) (NP (NP (DT the) (VBG following) (NN NaCl) (NNS steps)) (NP-2 (-NONE- *ICH*)))))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (DT this) (NN assay))) (: :) (NP-2 (NP (CD 0.90) (NN %)) (, ,) (NP (CD 0.65) (NN %)) (, ,) (NP (CD 0.60) (NN %)) (, ,) (NP (CD 0.55) (NN %)) (, ,) (NP (CD 0.50) (NN %)) (, ,) (NP (CD 0.45) (NN %)) (, ,) (NP (CD 0.40) (NN %)) (, ,) (NP (CD 0.35) (NN %)) (, ,) (NP (CD 0.30) (NN %)) (, ,) (NP (CD 0.10) (NN %))))) (. .)) )
( (S (PP (IN For) (NP (DT each) (NN step))) (NP-SBJ-1 (NP (NP (CD 5) (NNS ml)) (PP (IN of) (NP (DT the) (NN gradient) (NN step) (NN solution)))) (CC and) (NP (NML (CD 50) (NN μl)) (NN blood) (NN sample))) (VP (VBD were) (ADVP (RB carefully)) (VP (VP (VBN inverted) (NP-1 (-NONE- *)) (NP-TMP (CD four) (NNS times))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 30) (NNS minutes))) (PP (IN in) (NP (DT the) (NN dark)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (ADVP (RB carefully)) (VP (VP (VBN inverted) (NP-1 (-NONE- *)) (ADVP-TMP (RB again))) (CC and) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 1,500) (SYM ×) (NN g))) (PP-TMP (IN for) (NP (CD 10) (NNS minutes)))))) (. .)) )
( (S (PP (IN From) (NP (NP (NML (CD 1) (NN ml)) (NN supernatant)) (PP (IN of) (NP (DT each) (NN step))))) (NP-SBJ-1 (NP (DT the) (NN extinction)) (PP (IN at) (NP (NML (CD 546) (NN nm)) (NN wavelength)))) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN experiment)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN at) (NP (NN room) (NN temperature))))) (. .)) )
( (HEADING (NP (NML (NN Platelet) (NN aggregation)) (NN assay))) )
( (S (NP-SBJ-1 (NP (QP (RB Approximately) (CD 500)) (NNS μl)) (PP (IN of) (NP (JJ murine) (NN blood)))) (VP (VBD were) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 200) (SYM ×) (NN g))) (PP-TMP (IN for) (NP (CD 15) (NNS minutes))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBG resulting) (NNS supernatants)) (VP (VBD were) (VP (VP (VBN transferred) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ new) (NNS tubes)))) (CC and) (VP (VBN used) (NP-1 (-NONE- *)) (PP-MNR (IN as) (NP (NP (ADJP (NN platelet) (JJ rich)) (NN plasma)) (-LRB- -LRB-) (NP (NN PRP))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN platelet) (NN aggregation)) (NNS measurements)) (VP (VBD were) (VP (VBN done) (NP-1 (-NONE- *)) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NN method)) (VP (VBN developed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NNP Born) (CC and) (NNP Cross) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ])))))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT an) (NN APACT) (NN photometer) (PRN (-LRB- -LRB-) (NP (NN Labor)) (, ,) (NP (NN Ahrendsburg)) (, ,) (NP (NN FRG)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NN APACT) (NN software) (PRN (-LRB- -LRB-) (NP (NN APACT) (CD 1.4)) (-RRB- -RRB-)))))))) (. .)) )
( (S (ADVP-TMP (RB Subsequently)) (NP-SBJ-1 (NP (NNS samples)) (PP (IN of) (NP (DT the) (NN PRP)))) (VP (VBD were) (VP (VBN adjusted) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN buffer) (PRN (-LRB- -LRB-) (NP (NML (CD 5) (NN mM)) (NN Hepes)) (, ,) (NP (NML (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (NN pH) (CD 7.3)) (-RRB- -RRB-)))) (PP (IN to) (NP (NP (CD 250,000) (NNS platelets)) (PP (SYM /) (NP (NN μl))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ constant) (NN platelet) (NN count)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (ADVP (RB throughout)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG allowing) (NP (NP (NNS comparisons)) (PP (IN between) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN knock) (NN out))) (ADJP (JJ murine) (CC and) (JJ human)) (NNS samples)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NML (CD 250) (NN μl)) (VBN adjusted) (NNS platelets)) (VP (VBD were) (VP (VP (VBN prewarmed) (NP-1 (-NONE- *)) (PP (IN to) (NP (CD 37) (NNS °C)))) (CC and) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT the) (NN assay))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NN aggregation) (NN process)) (VP (VBD was) (VP (VBN started) (NP-2 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG adding) (NP (NP (CD 25) (NN μl)) (PP (IN of) (NP (NP (DT a) (JJ prewarmed) (NML (NML (CD 16.5) (NN mg)) (PP (SYM /) (NP (NN ml)))) (NN ristocetin) (NN solution) (PRN (-LRB- -LRB-) (NP (NNP DiaMed) (NNP Diagnostica)) (, ,) (NP (NNP Bensheim)) (, ,) (NP (NNP FRG)) (: ;) (FRAG (NP (NP (NN concentration)) (PP (IN in) (NP (DT the) (NN assay)))) (: :) (NP (NP (CD 1.5) (NNS mg)) (PP (SYM /) (NP (NN ml))))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN reagent)) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD worked) (ADVP (RB reliably)) (PP (IN in) (NP (PRP$ our) (NNS hands))) (PP (IN with) (NP (UCP (NN mouse) (CC and) (JJ human)) (NNS platelets)))))))))))))))) (. .)) )
( (S (NP-SBJ (DT Each) (JJ murine) (NN assay)) (VP (VBZ represents) (NP (DT a) (JJ different) (NN animal))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Analyses)) (PP (IN of) (NP (JJ human) (NN blood) (NNS samples)))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NN protocol)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Several) (JJ repeated) (NNS measurements)) (VP (VBD were) (VP (VBN done) (NP-1 (-NONE- *)) (PP (IN per) (NP (JJ human) (NN individual))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB control) (NP (DT the) (NN reproducibility))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (VBN acquired) (NML (NN aggregation) (NN curve)) (NNS data)) (, ,) (VP (VBN measured) (NP (-NONE- *)) (PP-MNR (IN as) (NP (NP (VBG ascending) (NN degree)) (PP (IN of) (NP (NN transmission))))))) (, ,) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ maximal) (NN slope) (NNS values))) (, ,) (SBAR-ADV (WHADVP-3 (IN while)) (S (NP-SBJ-2 (NP (DT the) (JJ maximal) (NN aggregation) (NN amplitude)) (PP (IN of) (NP (DT every) (JJ single) (NN curve)))) (VP (VBD was) (VP (VBN set) (NP-2 (-NONE- *)) (PP (IN to) (NP (CD 100) (NN %))))))))) (. .)) )
( (S (PP (IN In) (ADJP (JJ general))) (, ,) (NP-SBJ-1 (DT all) (NN platelet) (NNS procedures)) (VP (VBD were) (VP (VBN done) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 22) (NNS °C))) (PP-TMP (IN within) (NP (NP (CD four) (NNS hours)) (PP-TMP (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG collecting) (NP (DT the) (NN blood) (NN sample))))))))) (. .)) )
( (HEADING (NP (JJ Miscellaneous) (NNS methods))) )
( (S (PP-PRP (IN For) (NP (NP (JJ standard) (NML (NML (JJ haematopoetic) (NNS measurements)) (CC and) (NML (NN cell) (NNS counts)))) (PP (IN on) (NP (NML (JJ murine) (CC and) (JJ human)) (NN blood) (NNS samples))))) (NP-SBJ-1 (NP (QP (IN about) (CD 300)) (NNS μl)) (PP (IN of) (NP (NN blood)))) (VP (VBD were) (VP (VBN analysed) (NP-1 (-NONE- *)) (PP (IN with) (NP (DT an) (NML (NN ADVIA) (CD 120)) (JJ electronic) (NN cell) (NN counter) (PRN (-LRB- -LRB-) (NP (NN Bayer)) (-RRB- -RRB-)))))) (. .)) )
( (S (PP (IN With) (NP (DT this) (NN equipment))) (NP-SBJ-1 (NP (JJ red) (NN blood) (NNS cells)) (CC and) (NP (NNS platelets))) (VP (VBP are) (`` ``) (VP (VBN transformed) (NP-1 (-NONE- *)) ('' '') (PP (IN into) (NP (JJ spherical) (NNS bodies))) (PP-MNR (IN without) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG changing) (NP (PRP$ their) (NN volume))))))) (. .)) )
( (S (ADVP (RB Therefore)) (NP-SBJ (NP (NN number) (CC and) (NN volume)) (PP (IN of) (NP (NP (JJ red) (NN blood) (NNS cells)) (CC and) (NP (NNS platelets))))) (VP (VP (VBP are) (ADVP=2 (RB not)) (NP-PRD=1 (VBN calculated) (NNS values))) (, ,) (CC but) (VP (ADVP=2 (-NONE- *NOT*)) (NP-PRD=1 (ADJP (RB directly) (VBN measured)) (NNS values)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (VBG following) (NNS data)) (NP-2 (-NONE- *ICH*))) (VP (VBD were) (ADVP-MNR (RB statistically)) (VP (VBN analysed) (NP-1 (-NONE- *)) (: :) (NP-2 (NP (NNS leucocytes)) (, ,) (NP (JJ red) (NN blood) (NNS cells)) (, ,) (NP (NN haemoglobin)) (, ,) (NP (NN haematocrit)) (, ,) (NP (JJ mean) (JJ cellular) (NN volume)) (, ,) (NP (JJ mean) (JJ cellular) (NN haemoglobin)) (, ,) (NP (NML (JJ mean) (JJ cellular) (NN haemoglobin)) (NN concentration)) (, ,) (NP (NN platelet) (NN number)) (, ,) (NP (NNS neutrophiles)) (, ,) (NP (NNS lymphocytes)) (, ,) (NP (NNS monocytes)) (, ,) (NP (NNS eosinophiles)) (, ,) (NP (NNS basophiles))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Peptide) (NN mass)) (NN fingerprinting)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NNP Bruker) (NNP Reflex) (CD IV)) (NML (NN MALDI) (HYPH -) (NN TOF)) (NN mass) (NN spectrometer))))) (. .)) )
( (S (S (NP-SBJ-1 (JJ Recombinant) (NN annexin) (NN A7)) (VP (VBD was) (VP (VBN purified) (NP-1 (-NONE- *)) (PP-MNR (VBG according) (PP (IN to) (-LRB- [) (NP (CD 27))))))) (-RRB- ]) (, ,) (S (NP-SBJ-2 (NP (NML (NN F) (HYPH -) (NN actin)) (HYPH -) (VBG binding)) (PP (IN of) (NP (JJ recombinant) (NN annexin) (NN A7)))) (VP (VBD was) (VP (VBN done) (NP-2 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN described) (NP-3 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 28)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN SDS) (HYPH -) (NN PAGE)) (CC and) (NP (JJ western) (NN blotting))) (VP (VBD were) (VP (VBN done) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 29) (, ,) (CD 30)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (NN Detection)) (PP (IN in) (NP (NNS immunoblots)))) (VP (VBD was) (PP-PRD (IN with) (NP (VBN enhanced) (NN chemiluminescence))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (NNS Antibodies)) (VP (VBN employed) (NP (-NONE- *)))) (VP (VBD were) (NP-PRD (NP (NN mab) (NML (NML (CD 203)) (PP (SYM –) (NP (CD 217))))) (VP (VBN directed) (NP (-NONE- *)) (PP (IN against) (NP (NP (NN mouse) (NML (NN annexin) (NN A7)) (NN core) (NN domain) (PRN (-LRB- [) (NP (CD 5)) (-RRB- ]))) (CC and) (NP (DT a) (JJ polyclonal) (NN rabbit) (JJ anti-sorcin) (NN antibody) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))))))) (. .)) )
( (S (PP-PRP (IN For) (NP (JJ statistical) (NNS analyses))) (NP-SBJ-1 (NP (DT the) (VBG following) (NNS tests)) (NP-3 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (: :) (NP-3 (NP (NP (NML (NML (NNP David)) (ADVP-ETC (FW et) (FW al.))) (NN range) (NN test)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB ensure) (SBAR (-NONE- *0*) (S (NP-SBJ (NNS samples)) (VP (VBP are) (PP-PRD (IN from) (NP (DT a) (JJ normal) (NN distribution))))))))))) (, ,) (NP (NP (NN F) (HYPH -) (NN test)) (VP (VBG looking) (PP (IN for) (NP (NP (DT a) (NNS samples) (POS ')) (NN homoscedascity))))) (, ,) (NP (NP (NP (NN Student) (POS 's)) (NN T) (HYPH -) (NN test)) (SBAR (WHNP-4 (-NONE- *0*)) (S (NP-SBJ-4 (-NONE- *T*)) (VP (TO to) (VP (VB judge) (SBAR (IN if) (S (NP-SBJ (NP (NNS samples)) (PP (IN of) (NP (JJ different) (NNS groups)))) (VP (VP (VBP have) (NP (DT a) (JJ different) (JJ mean) (NN value))) (CC and) (VP (VBP are) (NP-PRD (NNS parts)) (PP (IN from) (NP (JJ different) (JJ normal) (NNS distributions))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ exact) (NN probability) (NNS values)) (CC and) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (DT an) (NN analysis))))) (VP (VBP are) (VP (VBN indicated) (NP-1 (-NONE- *)) (SBAR-ADV (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (DT the) (NNS experiments)) (VP (VBP are) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP-3 (-NONE- *T*)))))))) (. .)) )
( (HEADING (NP (NP (NNS Authors) (POS ')) (NNS contributions))) )
( (S (S (NP-SBJ (NN CH) (CC and) (NN CSC)) (VP (VP (VP (VBD planned) (NP-1 (-NONE- *RNR*))) (CC and) (VP (VBD carried) (PRT (RP out)) (NP-1 (-NONE- *RNR*))) (NP-1 (NP (NP (DT the) (NNS experiments)) (PP (IN with) (NP (DT the) (NML (NML (JJ red) (NN blood) (NNS cells)) (CC and) (NML (NNS platelets)))))) (CC and) (NP (DT the) (NN fractionation) (NNS studies)))) (CC and) (VP (VBD drafted) (NP (DT the) (NN manuscript))))) (, ,) (S (NP-SBJ (NN GL)) (VP (VBD was) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NNS platelets)))))) (, ,) (S (NP-SBJ (NN RK)) (VP (VP (VBD gave) (NP (NN support)) (PP (IN on) (NP (DT the) (NML (NN ADVIA) (CD 120)) (NN cell) (NN counter)))) (, ,) (VP (VBD evaluated) (CC and) (VBD discussed) (NP (DT the) (NNS results))))) (, ,) (S (NP-SBJ (NN SMP) (CC and) (NN BSG)) (VP (VP (VBD gave) (NP (NN support)) (PP (IN on) (NP (NP (DT the) (NN APACT) (NN system)) (, ,) (NP (NML (NN platelet) (NN aggregation)) (NNS experiments))))) (, ,) (CC and) (VP (VBD evaluated) (NP (DT the) (NNS results))))) (, ,) (S (NP-SBJ (NN CZ)) (VP (VBD was) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (DT the) (NN sorcin) (NNS studies)))))) (, ,) (S (NP-SBJ (NN MS)) (VP (VBD studied) (NP (NP (DT the) (JJ cytoskeletal) (NNS activities)) (PP (IN of) (NP (DT the) (NN protein)))))) (, ,) (S (NP-SBJ (NN AAN)) (VP (VP (VBD conceived) (PP (IN of) (NP (DT the) (NNS studies)))) (CC and) (VP (VBD participated) (PP (IN in) (NP (PRP$ its) (NN design)))))) (. .)) )
( (S (NP-SBJ (DT All) (NNS authors)) (VP (VBD read) (CC and) (VBD approved) (NP (DT the) (NN manuscript))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ-1 (PRP We)) (VP (MD would) (VP (VB like) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB thank) (NP=2 (NP (NNP M.) (NN Heil)) (, ,) (NP (NNP B.) (NN Hoffmann)) (CC and) (NP (NNP R.) (NNP Merkel))) (PP=3 (IN for) (NP (DT the) (JJ biophysical) (NNS experiments)))) (, ,) (VP (NP=2 (NNP L.) (NNP Eichinger)) (PP=3 (IN for) (NP (NN discussion)))) (, ,) (VP (NP=2 (NNP B.) (VBN Gassen)) (PP=3 (IN for) (NP (JJ expert) (JJ technical) (NN assistance)))) (CC and) (VP (NP=2 (NNP R.) (NN Müller)) (PP=3 (IN for) (NP (NN protein) (NN purification))))))))) (. .)) )
( (S (NP-SBJ-1 (NNP Mass) (JJ spectrometric) (NN analysis)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ central) (NN service) (NNS facilities)) (PP (IN of) (NP (DT the) (NN ZMMK))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN worked)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN grant)) (PP (IN from) (NP (NP (DT the) (NN ZMMK)) (-LRB- -LRB-) (NP (NP (NP (NNP Center)) (PP (IN of) (NP (NNP Molecular) (NNP Medicine)))) (NP-LOC (NNP Cologne))) (-RRB- -RRB-))))))) (. .)) )
